{"title": "Mignon Lee-Cheun Loh, MD", "author": "Dante Quincy; CA", "url": "https://www.seattlechildrens.org/directory/mignon-lee-cheun-loh/", "hostname": "seattlechildrens.org", "description": "Mignon Lee-Cheun Loh, MD, Chief, Division of Pediatric Hematology, Oncology, Bone Marrow Transplant and Cellular Therapy, Director, Ben Towne Center for Childhood Cancer Research, Professor, Pediatrics", "sitename": "Seattle Children's Hospital", "date": "2022-01-20", "cleaned_text": "Mignon Lee-Cheun Loh, MD [Cancer and Blood Disorders Center](https://www.seattlechildrens.org/clinics/cancer/), [Leukemia Program](https://www.seattlechildrens.org/clinics/cancer/services/leukemia-lymphoma/) On staff since Title: Chief, Division of Pediatric Hematology, Oncology, Bone Marrow Transplant and Cellular Therapy Academic Title: Professor, Pediatrics Research Title: Director, Ben Towne Center for Childhood Cancer Research Foundation Title: Aldarra Foundation, Bill and June Boeing Founders, Endowed Chair in Pediatric Cancer Research Research Center: [Ben Towne Center for Childhood Cancer Research](https://www.seattlechildrens.org/research/centers-programs/childhood-cancer/) - Dr. Mignon Loh is center director for the Ben Towne Center for Childhood Cancer Research and chief of the Division of Pediatric Hematology, Oncology, Bone Marrow Transplant and Cellular Therapy, overseeing the Cancer and Blood Disorders Center at Seattle Children's Hospital. Her research focuses on how and why leukemia progresses, as well as making genomics discoveries in the lab that translate into new and better diagnostics and therapeutics for children, adolescents and young adults with leukemia. - - Dr. Mignon Loh is simply THE BEST. Her brilliant and compassionate care of my daughter saved her life and has given her a bright and promising future, despite being a leukemia survivor. Dr. Loh is an expert who listens and cares deeply about her patients. I trust her completely. She is a rock-star doctor and our family's heroine. - Dr. Loh treated our daughter at UCSF. She was very responsive and caring to our daughter and our entire family. Simply, she and her staff were wonderful! - - Other Publications - Wintering A, Ishiyama K, Tamaki S, Tamaki C, Fandel J, Ji L, Wood BL, Shah NN, Yuan CM, O'Brien MM, Loh ML, Diaz-Flores ECD22low/Bcl-2high expression identifies poor response to inotuzumab ozogamicin in relapsed/refractory acute lymphoblastic leukemia. 35500285 Blood advances, 2023 Jan 24 : 7(2)251-255 - Wintering A, Ishiyama K, Tamaki S, Tamaki C, Fandel J, Ji L, Wood BL, Shah NN, Yuan CM, O'Brien MM, Loh ML, Diaz-Flores ECD22low/Bcl-2high expression identifies poor response to inotuzumab ozogamicin in relapsed/refractory acute lymphoblastic leukemia. 35500285 Blood advances, 2023 Jan 24 : 7(2)251-255 - Wintering A, Ishiyama K, Tamaki S, Tamaki C, Fandel J, Ji L, Wood BL, Shah NN, Yuan CM, O'Brien MM, Loh ML, Diaz-Flores ECD22low/Bcl-2high expression identifies poor response to inotuzumab ozogamicin in relapsed/refractory acute lymphoblastic leukemia. 35500285 Blood advances, 2023 Jan 24 : 7(2)251-255 - Gossai N, Devidas M, Chen Z, Wood PA, KR, Loh ML, Raetz MJ, Carroll WL, Hunger SP, Dunsmore KP, Winter SS, Teachey DTCentral Leukemia: A Children's Oncology Group 36603187 Blood, 2023 Jan 5 - Gossai N, Devidas M, Chen Z, Wood BL, Zweidler-McKay PA, KR, Loh ML, Raetz MJ, Carroll WL, Hunger SP, Dunsmore KP, Winter SS, Teachey DTCentral Leukemia: A Children's Oncology Group 36603187 Blood, 2023 Jan 5 - Gossai N, Devidas M, Chen Z, Wood BL, Zweidler-McKay PA, KR, Loh ML, Raetz MJ, Carroll WL, Hunger SP, Dunsmore KP, Winter SS, Teachey DTCentral Leukemia: A Children's Oncology Group 36603187 Blood, 2023 Jan 5 - Gossai N, Devidas M, Chen Z, Wood BL, Zweidler-McKay PA, KR, Loh ML, Raetz MJ, Carroll WL, Hunger SP, Dunsmore KP, Winter SS, Teachey DTCentral Leukemia: A Children's Oncology Group 36603187 Blood, 2023 Jan 5 - Gossai N, Devidas M, Chen Z, Wood BL, Zweidler-McKay PA, KR, Loh ML, Raetz MJ, Carroll WL, Hunger SP, Dunsmore KP, Winter SS, Teachey DTCentral Leukemia: A Children's Oncology Group 36603187 Blood, 2023 Jan 5 - Gossai N, Devidas M, Chen Z, Wood BL, Zweidler-McKay PA, KR, Loh ML, Raetz MJ, Carroll WL, Hunger SP, Dunsmore KP, Winter SS, Teachey DTCentral Leukemia: A Children's Oncology Group 36603187 Blood, 2023 Jan 5 - Gossai N, Devidas M, Chen Z, Wood BL, Zweidler-McKay PA, KR, Loh ML, Raetz MJ, Carroll WL, Hunger SP, Dunsmore KP, Winter SS, Teachey DTCentral Leukemia: A Children's Oncology Group Report. 36603187 Blood, 2023 Jan 5 - Escherich CS, Chen W, Miyamoto S, Namikawa Y, Yang W, Teachey DT, Li Z, Raetz EA, Larsen EC, Devidas M, Martin PL, Bowman WP, Wu G, Pui CH, Hunger SP, Loh ML, Takagi M, Yang JJIdentification of TCF3 germline variants in pediatric B-cell acute 36576946 Blood advances, 2022 Dec 28 - Escherich CS, Chen W, Miyamoto S, Namikawa Y, Yang W, Teachey DT, Li Z, Raetz EA, Larsen EC, Devidas M, Martin PL, Bowman WP, Wu G, Pui CH, Hunger SP, Loh ML, Takagi M, Yang JJIdentification of TCF3 germline variants in pediatric B-cell acute 36576946 Blood advances, 2022 Dec 28 - Escherich CS, Chen W, Miyamoto S, Namikawa Y, Yang W, Teachey DT, Li Z, Raetz EA, Larsen EC, Devidas M, Martin PL, Bowman WP, Wu G, Pui CH, Hunger SP, Loh ML, Takagi M, Yang JJIdentification of TCF3 germline variants in pediatric B-cell acute 36576946 Blood advances, 2022 Dec 28 - Escherich CS, Chen W, Miyamoto S, Namikawa Y, Yang W, Teachey DT, Li Z, Raetz EA, Larsen EC, Devidas M, Martin PL, Bowman WP, Wu G, Pui CH, Hunger SP, Loh ML, Takagi M, Yang JJIdentification of TCF3 germline variants in pediatric B-cell acute lymphoblastic leukemia. 36576946 Blood advances, 2022 Dec 28 - Yang W, Karol SE, Hoshitsuki K, Lee S, Larsen EC, Winick N, Carroll WL, Loh ML, Raetz EA, Hunger SP, SS, Dunsmore KP, Devidas M, Relling MV, Yang JJAssociation of Inherited Genetic Factors With Drug-Induced Hepatic Damage Among Children With Acute Lymphoblastic Leukemia. 36580335 JAMA network open, 2022 Dec 1 : 5(12)e2248803 - Yang W, Karol SE, Hoshitsuki K, Lee S, Larsen EC, Winick N, Carroll WL, Loh ML, Raetz EA, Hunger SP, SS, Dunsmore KP, Devidas M, Relling MV, Yang JJAssociation of Inherited Genetic Factors With Drug-Induced Hepatic Damage Among Children With Acute Lymphoblastic Leukemia. 36580335 JAMA network open, 2022 Dec 1 : 5(12)e2248803 - Yang W, Karol SE, Hoshitsuki K, Lee S, Larsen EC, Winick N, Carroll WL, Loh ML, Raetz EA, Hunger SP, SS, Dunsmore KP, Devidas M, Relling MV, Yang JJAssociation of Inherited Genetic Factors With Drug-Induced Hepatic Damage Among Children With Acute Lymphoblastic Leukemia. 36580335 JAMA network open, 2022 Dec 1 : 5(12)e2248803 - Yang W, Karol SE, Hoshitsuki K, Lee S, Larsen EC, Winick N, Carroll WL, Loh ML, Raetz EA, Hunger SP, SS, Dunsmore KP, Devidas M, Relling MV, Yang JJAssociation of Inherited Genetic Factors With Drug-Induced Hepatic Damage Among Children With Acute Lymphoblastic Leukemia. 36580335 JAMA network open, 2022 Dec 1 : 5(12)e2248803 - Yang W, Karol SE, Hoshitsuki K, Lee S, Larsen EC, Winick N, Carroll WL, Loh ML, Raetz EA, Hunger SP, SS, Dunsmore KP, Devidas M, Relling MV, Yang JJAssociation of Inherited Genetic Factors With Drug-Induced Hepatic Damage Among Children With Acute Lymphoblastic Leukemia. 36580335 JAMA network open, 2022 Dec LC, Aya-Bonilla C, Cruickshank MN, Chiu SK, Kuek V, Anderson D, Chua GA, Singh S, Oommen J, Ferrari E, Hughes AM, Ford J, Kunold E, Hesselman MC, Post F, Faulk KE, Breese EH, Guest EM, Brown PA, Loh ML, Lock RB, Kees UR, Jafari R, Malinge S, venetoclax for infant KMT2A-rearranged acute lymphoblastic leukemia reveals a new therapeutic strategy. 36380143 Leukemia, 2022 Nov 15 - Cheung LC, Aya-Bonilla C, Cruickshank MN, Chiu SK, Kuek V, Anderson D, Chua GA, Singh S, Oommen J, Ferrari E, Hughes AM, Ford J, Kunold E, Hesselman MC, Post F, Faulk KE, Breese EH, Guest EM, Brown PA, Loh ML, Lock RB, Kees UR, Jafari R, Malinge S, venetoclax for infant KMT2A-rearranged acute lymphoblastic leukemia reveals a new therapeutic strategy. 36380143 Leukemia, 2022 Nov 15 - Cheung LC, Aya-Bonilla C, Cruickshank MN, Chiu SK, Kuek V, Anderson D, Chua GA, Singh S, Oommen J, Ferrari E, Hughes AM, Ford J, Kunold E, Hesselman MC, Post F, Faulk KE, Breese EH, Guest EM, Brown PA, Loh ML, Lock RB, Kees UR, Jafari R, Malinge S, venetoclax for infant KMT2A-rearranged acute lymphoblastic leukemia reveals a new therapeutic strategy. 36380143 Leukemia, 2022 Nov 15 - Cheung LC, Aya-Bonilla C, Cruickshank MN, Chiu SK, Kuek V, Anderson D, Chua GA, Singh S, Oommen J, Ferrari E, Hughes AM, Ford J, Kunold E, Hesselman MC, Post F, Faulk KE, Breese EH, Guest EM, Brown PA, Loh ML, Lock RB, Kees UR, Jafari R, Malinge S, venetoclax for infant KMT2A-rearranged acute lymphoblastic leukemia reveals a new therapeutic strategy. 36380143 Leukemia, 2022 Nov 15 - Elitzur S, Vora B, Inaba H, Attarbaschi A, Baruchel A, Escherich G, Gibson BE, Liu HC, Loh ML, Moorman AV, M\u00f6ricke A, Pieters R, Uyttebroeck Baird S, Bartram J, Barzilai-Birenboim S, Batra S, Ben-Harosh M, Bertrand Y, Buitenkamp T, Caldwell K, Drut R, Geerlinks AV, Gilad G, Grainger J, Haouy Manabe with pediatric ALL maintenance therapy. 36332176 Blood, 2022 Nov 4 - Elitzur S, Vora B, Inaba H, Attarbaschi A, Baruchel A, Escherich G, Gibson BE, Liu HC, Loh ML, Moorman AV, M\u00f6ricke A, Pieters R, Uyttebroeck Baird S, Bartram J, Barzilai-Birenboim S, Batra S, Ben-Harosh M, Bertrand Y, Buitenkamp T, Caldwell K, Drut R, Geerlinks AV, Gilad G, Grainger J, Haouy Manabe with pediatric ALL maintenance therapy. 36332176 Blood, 2022 Nov 4 - Elitzur S, Vora B, Inaba H, Attarbaschi A, Baruchel A, Escherich G, Gibson BE, Liu HC, Loh ML, Moorman AV, M\u00f6ricke A, Pieters R, Uyttebroeck Baird S, Bartram J, Barzilai-Birenboim S, Batra S, Ben-Harosh M, Bertrand Y, Buitenkamp T, Caldwell K, Drut R, Geerlinks AV, Gilad G, Grainger J, Haouy Manabe with pediatric ALL maintenance therapy. 36332176 Blood, 2022 Nov 4 - Fries C, Lee LW, Devidas M, Dai Y, Rabin KR, Gupta S, Loh ML, Kirsch IR, Wood B, Rau impact leukemia. 36325891 Nov 3 - Fries C, Lee LW, Devidas M, Dai Y, Rabin KR, Gupta S, Loh ML, Kirsch IR, Wood B, Rau impact leukemia. 36325891 Nov 3 - Fries C, Lee LW, Devidas M, Dai Y, Rabin KR, Gupta S, Loh ML, Kirsch IR, Wood B, Rau impact A, Forouhar F, Laurent AP, Lin WW, Albero R, Miller HI, Ma C, Gastier-Foster JM, Loh ML, Tong L, Stockwell BR, Palomero AAPharmacologic Inhibition of NT5C2 Reverses and Drivers of 6-MP Resistance in Acute Lymphoblastic Leukemia. 35984649 Cancer discovery, 2022 C, Dieck Zask A, Forouhar F, Laurent AP, Lin WW, Albero R, Miller HI, Ma C, Gastier-Foster JM, Loh ML, Tong L, Stockwell BR, Palomero AAPharmacologic Inhibition of NT5C2 Reverses and Drivers of 6-MP Resistance in Acute Lymphoblastic Leukemia. 35984649 Cancer discovery, 2022 Nov 2 : 12(11)2646-2665 PMCID:PMC9633388 - de Blank PMK, Gross AM, Akshintala S, Blakeley JO, Bollag G, Cannon A, Dombi E, J, Gelb BD, Hargrave D, Kim A, Klesse LJ, Loh M, Martin S, Moertel C, Packer R, JM, Rauen KA, Rios JJ, Robison N, Schorry EK, K, Stevenson DA, Stieglitz E, Ullrich NJ, Walsh KS, Weiss BD, Wolters PL, Yohay ME, Fisher MJMEK inhibitors for neurofibromatosis type 1 manifestations: Clinical evidence and consensus. 35788692 Neuro-oncology, Zask A, Forouhar F, Laurent AP, Lin WW, Albero R, Miller HI, Ma C, Gastier-Foster JM, Loh ML, Tong L, Stockwell BR, Palomero AAPharmacologic Inhibition of NT5C2 Reverses and Drivers of 6-MP Resistance in Acute Lymphoblastic Leukemia. 35984649 Cancer discovery, 2022 Nov 2 : 12(11)2646-2665 PMCID:PMC9633388 - de Blank PMK, Gross AM, Akshintala S, Blakeley JO, Bollag G, Cannon A, Dombi E, J, Gelb BD, Hargrave D, Kim A, Klesse LJ, Loh M, Martin S, Moertel C, Packer R, JM, Rauen KA, Rios JJ, Robison N, Schorry EK, K, Stevenson DA, Stieglitz E, Ullrich NJ, Walsh KS, Weiss BD, Wolters PL, Yohay ME, Fisher MJMEK inhibitors for neurofibromatosis type 1 manifestations: Clinical evidence and consensus. 35788692 Neuro-oncology, 2022 Nov 2 : 24(11)1845-1856 PMCID:PMC9629420 - PMK, Gross AM, Akshintala S, Blakeley JO, Bollag G, Cannon A, Dombi E, J, Gelb BD, Hargrave D, Kim A, Klesse LJ, Loh M, Martin S, Moertel C, Packer R, JM, Rauen KA, Rios JJ, Robison N, Schorry EK, K, Stevenson DA, Stieglitz E, Ullrich NJ, Walsh KS, Weiss BD, Wolters PL, Yohay ME, Fisher MJMEK inhibitors for neurofibromatosis type 1 manifestations: Clinical evidence and consensus. 35788692 Neuro-oncology, 2022 Nov 2 : 24(11)1845-1856 PMCID:PMC9629420 - Elgarten CW, Thompson JC, Angiolillo A, Chen Z, Conway S, Devidas M, Gupta S, Kairalla JA, McNeer JL, O'Brien MM, Rabin KR, Rau RE, Rheingold SR, Wang C, Wood C, Raetz EA, Loh ML, Alexander S, Miller TPImproving infectious adverse event reporting for children and adolescents enrolled in clinical trials for acute lymphoblastic leukemia: A report from the Children's Oncology Group. 36083863 Pediatric blood & cancer, 2022 Nov. : 69(11)e29937 PMCID:PMC9529813 - Elgarten CW, Thompson JC, Angiolillo A, Chen Z, Conway S, Devidas M, Gupta S, Kairalla JA, McNeer JL, O'Brien MM, Rabin KR, Rau RE, Rheingold SR, Wang C, Wood C, Raetz EA, Loh ML, Alexander S, Miller TPImproving infectious adverse event reporting for children and adolescents enrolled in clinical trials for acute lymphoblastic leukemia: A report from the Children's Oncology Group. 36083863 Pediatric blood & cancer, 2022 Nov. : 69(11)e29937 PMCID:PMC9529813 - Elgarten CW, Thompson JC, Angiolillo A, Chen Z, Conway S, Devidas M, Gupta S, Kairalla JA, McNeer JL, O'Brien MM, Rabin KR, Rau RE, Rheingold SR, Wang C, Wood C, Raetz EA, Loh ML, Alexander S, Miller TPImproving infectious adverse event reporting for children and adolescents enrolled in clinical trials for acute lymphoblastic leukemia: A report from the Children's Oncology Group. 36083863 Pediatric blood & cancer, 2022 Nov. : 69(11)e29937 PMCID:PMC9529813 - Ohki K, Butler ER, U, Haas OA, Harrison CJ, Moorman AV, Manabe AClinical outcomes of B-cell precursor ALL with MEF2D rearrangements: a retrospective study by the Ponte di Legno Childhood ALL Working Group. 36309560 Leukemia, 2022 Oct 29 - Ohki K, Butler ER, Kiyokawa N, Hirabayashi S, Bergmann U, Haas OA, Harrison CJ, Moorman AV, Manabe AClinical outcomes of B-cell precursor ALL with MEF2D rearrangements: a retrospective study by the Ponte di Legno Childhood ALL Working Group. 36309560 Leukemia, 2022 Oct 29 - Ohki K, Butler ER, Kiyokawa N, Hirabayashi S, Bergmann U, Haas OA, Harrison CJ, Moorman AV, Manabe AClinical outcomes of B-cell precursor ALL with MEF2D rearrangements: a retrospective study by the Ponte di Legno Childhood ALL Working Group. 36309560 Leukemia, 2022 Oct 29 - Attarbaschi A, M\u00f6ricke A, Harrison CJ, Mann G, Baruchel A, Moerloose B, Conter V, Devidas M, Elitzur S, Escherich G, Hunger SP, Horibe K, Manabe A, Loh ML, Pieters R, Schmiegelow Acute With 11q23/KMT2A Rearrangements in a Modern Therapy Era: A Retrospective International Study. 36256911 Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2022 Oct 18 : JCO2201297 - Attarbaschi A, M\u00f6ricke A, Harrison CJ, Mann G, A, Moerloose B, Conter V, Devidas M, Elitzur S, Escherich G, Hunger SP, Horibe K, Manabe A, Loh ML, Pieters R, Schmiegelow Acute With 11q23/KMT2A Rearrangements in a Modern Therapy Era: A Retrospective International Study. 36256911 Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2022 Oct 18 : JCO2201297 - Attarbaschi A, M\u00f6ricke A, Harrison CJ, Mann G, A, Moerloose B, Conter V, Devidas M, Elitzur S, Escherich G, Hunger SP, Horibe K, Manabe A, Loh ML, Pieters R, Schmiegelow Acute With 11q23/KMT2A Rearrangements in a Modern Therapy Era: A Retrospective International Study. 36256911 Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2022 Oct 18 : JCO2201297 T, Branford S, Bueso-Ramos CE, Cortes JE, R, Jabbour EJ, Kiladjian JJ, Larson RA, Le Beau MM, Loh L\u00f6wenberg B, Macintyre E, Malcovati Schiffer CA, Schmitt-Graeff A, Shimamura A, Sierra J, Stock WA, Stone RM, Tallman MS, Thiele J, Tien HF, Tzankov A, Vannucchi AM, Vyas P, Wei AH, Weinberg OK, Wierzbowska A, Cazzola M, D\u00f6hner H, Tefferi AInternational morphologic, clinical, and Blood, T, Branford S, Bueso-Ramos CE, Cortes JE, R, Jabbour EJ, Kiladjian JJ, Larson RA, Le Beau MM, Loh L\u00f6wenberg B, Macintyre E, Malcovati Schiffer CA, Schmitt-Graeff A, Shimamura A, Sierra J, Stock WA, Stone RM, Tallman MS, Thiele J, Tien HF, Tzankov A, Vannucchi AM, Vyas P, Wei AH, Weinberg OK, Wierzbowska A, Cazzola M, D\u00f6hner H, Tefferi AInternational morphologic, clinical, and 15 : 140(11)1200-1228 PMCID:PMC9479031 - Maese LD, Loh ML, Choi MR, Lin T, Aoki E, Zanette M, Agarwal S, Iannone Phase 2/3 AALL1931 Study. 36108304 Blood, 2022 Sep 15 - Maese LD, Loh ML, Choi MR, Lin T, Aoki E, Zanette M, Agarwal S, Iannone Phase 2/3 AALL1931 Study. 36108304 Blood, 2022 Sep 15 - Maese LD, Loh ML, Choi MR, Lin T, Aoki E, Zanette M, Agarwal S, Iannone Phase 2/3 AALL1931 Study. 36108304 Blood, 2022 Sep 15 T, Branford S, Bueso-Ramos CE, Cortes JE, R, Jabbour EJ, Kiladjian JJ, Larson RA, Le Beau MM, Loh L\u00f6wenberg B, Macintyre E, Malcovati Schiffer CA, Schmitt-Graeff A, Shimamura A, Sierra J, Stock WA, Stone RM, Tallman MS, Thiele J, Tien HF, Tzankov A, Vannucchi AM, Vyas P, Wei AH, Weinberg OK, Wierzbowska A, Cazzola M, D\u00f6hner H, Tefferi AInternational morphologic, clinical, and 35767897 Blood, 2022 Sep 15 : 140(11)1200-1228 PMCID:PMC9479031 - Zhao X, Qian M, Goodings C, Zhang Y, Yang W, Wang P, Xu B, Tian C, Pui CH, Hunger SP, Raetz EA, Devidas M, Relling MV, Loh ML, Savic D, Li C, Yang JJMolecular Mechanisms of ARID5B-Mediated Genetic Susceptibility to Acute Lymphoblastic Leukemia. 35575404 Journal of the National Cancer Institute, 2022 Sep 9 : 114(9)1287-1295 PMCID:PMC9468286 - Zhao X, Qian M, Goodings C, Zhang Y, Yang W, Wang P, Xu B, Tian C, Pui CH, Hunger SP, Raetz EA, Devidas M, Relling MV, Loh ML, Savic D, Li C, Yang JJMolecular Mechanisms of ARID5B-Mediated Genetic Susceptibility to Acute Lymphoblastic Leukemia. 35575404 Journal of the National Cancer Institute, 2022 Sep 9 : 114(9)1287-1295 PMCID:PMC9468286 - Zhao X, Qian M, Goodings C, Zhang Y, Yang W, Wang P, Xu B, Tian C, Pui CH, Hunger SP, Raetz EA, Devidas M, Relling MV, Loh ML, Savic D, Li C, Yang JJMolecular Mechanisms of ARID5B-Mediated Genetic Susceptibility to Acute Lymphoblastic Leukemia. 35575404 Journal of the National Cancer Institute, 2022 Sep 9 : 114(9)1287-1295 PMCID:PMC9468286 - Brady SW, Roberts KG, Gu Z, Shi L, Pounds S, Pei D, Cheng C, Dai Y, Devidas M, Qu C, Hill AN, Payne-Turner D, Ma X, Iacobucci I, Baviskar P, Wei L, Arunachalam S, Hagiwara K, Liu Y, Flasch DA, Liu Y, Parker M, Chen X, Elsayed AH, Pathak O, Li Y, Fan Y, Michael JR, Rusch M, Wilkinson MR, Foy S, Hedges DJ, Newman S, Zhou X, Wang J, Reilly C, Sioson E, Rice SV, Pastor Loyola V, Wu Auvil N, Carroll AJ, Heerema RC, KP, Crews KR, Downing Jeha S, Pui CH, Evans WE, Yang JJ, Relling MV, Gerhard DS, Loh ML, Hunger SP, Zhang J, Mullighan CGThe genomic landscape of pediatric acute lymphoblastic leukemia. 36050548 Nature genetics, 2022 Sept. : 54(9)1376-1389 PMCID:PMC9700506 - Brady SW, Roberts KG, Gu Z, Shi L, Pounds S, Pei D, Cheng C, Dai Y, Devidas M, Qu C, Hill AN, Payne-Turner D, Ma X, Iacobucci I, Baviskar P, Wei L, Arunachalam S, Hagiwara K, Liu Y, Flasch DA, Liu Y, Parker M, Chen X, Elsayed AH, Pathak O, Li Y, Fan Y, Michael JR, Rusch M, Wilkinson MR, Foy S, Hedges DJ, Newman S, Zhou X, Wang J, Reilly C, Sioson E, Rice SV, Pastor Loyola V, Wu Auvil N, Carroll AJ, Heerema RC, KP, Crews KR, Downing Jeha S, Pui CH, Evans WE, Yang JJ, Relling MV, Gerhard DS, Loh ML, Hunger SP, Zhang J, Mullighan CGThe genomic landscape of pediatric acute lymphoblastic leukemia. 36050548 Nature genetics, 2022 Sept. : 54(9)1376-1389 PMCID:PMC9700506 - Brady SW, Roberts KG, Gu Z, Shi L, Pounds S, Pei D, Cheng C, Dai Y, Devidas M, Qu C, Hill AN, Payne-Turner D, Ma X, Iacobucci I, Baviskar P, Wei L, Arunachalam S, Hagiwara K, Liu Y, Flasch DA, Liu Y, Parker M, Chen X, Elsayed AH, Pathak O, Li Y, Fan Y, Michael JR, Rusch M, Wilkinson MR, Foy S, Hedges DJ, Newman S, Zhou X, Wang J, Reilly C, Sioson E, Rice SV, Pastor Loyola V, Wu Auvil N, Carroll AJ, Heerema RC, KP, Crews KR, Downing Jeha S, Pui CH, Evans WE, Yang JJ, Relling MV, Gerhard DS, Loh ML, Hunger SP, Zhang J, Mullighan CGThe genomic landscape of pediatric acute lymphoblastic leukemia. genetics, 2022 Sept. : 54(9)1376-1389 PMCID:PMC9700506 - Imaizumi T, Meyer J, Wakamatsu M, Kitazawa Murakami N, Okuno Y, Yoshida T, Sajiki D, Hama A, Kojima S, Takahashi Y, Loh M, Stieglitz E, Muramatsu HClinical parameter-based prediction of DNA methylation classification generates a prediction model of prognosis in patients with juvenile myelomonocytic leukemia. 36042365 Scientific reports, 2022 Aug 30 : 12(1)14753 PMCID:PMC9427938 - Imaizumi T, Meyer J, Wakamatsu M, Kitazawa Murakami N, Okuno Y, Yoshida T, Sajiki D, Hama A, Kojima S, Takahashi Y, Loh M, Stieglitz E, Muramatsu HClinical parameter-based prediction of DNA methylation classification generates a prediction model of prognosis in patients with juvenile myelomonocytic leukemia. 36042365 Scientific reports, 2022 Aug 30 : 12(1)14753 PMCID:PMC9427938 - Imaizumi T, Meyer J, Wakamatsu M, Kitazawa Murakami N, Okuno Y, Yoshida T, Sajiki D, Hama A, Kojima S, Takahashi Y, Loh M, Stieglitz E, Muramatsu HClinical parameter-based prediction of DNA methylation classification generates a prediction model of prognosis in patients with juvenile myelomonocytic leukemia. 36042365 Scientific reports, 2022 Aug AL, KK, Kadan-Lottick NSPersistence Vincristine Reduction in Childhood B-Acute Lymphoblastic Leukemia. 35552709 Journal of the National Cancer Institute, Aug 8 : 114(8)1167-1175 PMCID:PMC9360458 - AL, KK, Kadan-Lottick NSPersistence Vincristine Reduction in Childhood B-Acute Lymphoblastic Leukemia. 35552709 Journal of the National Cancer Institute, Aug 8 : 114(8)1167-1175 PMCID:PMC9360458 - AL, KK, Kadan-Lottick NSPersistence Vincristine Reduction in Childhood B-Acute Lymphoblastic Leukemia. 35552709 Journal of the National Cancer Institute, 2022 Aug 8 : 114(8)1167-1175 PMCID:PMC9360458 - Teachey Galardy PJ, Harker-Murray P, Horton TM, Jaju AI, Lam A, Messinger YH, Miles RR, Okada M, Patel SI, Schafer ES, Schechter T, Singh N, Steele AC, Sulis ML, Vargas SL, Winter SS, Wood C, Zweidler-McKay P, Bollard CM, Loh ML, Hunger SP, Raetz EAChildren's Oncology Group Trial AALL1231: A Phase III Clinical Trial Testing Bortezomib in Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia and Lymphoma. 35271306 Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2022 Jul 1 : 40(19)2106-2118 PMCID:PMC9242409 - Galardy PJ, Harker-Murray P, Horton TM, Jaju AI, Lam A, Messinger YH, Miles RR, Okada M, Patel SI, Schafer ES, Schechter T, Singh N, Steele AC, Sulis ML, Vargas SL, Winter SS, Wood C, Zweidler-McKay P, Bollard CM, Loh ML, Hunger SP, Raetz EAChildren's Oncology Group Trial AALL1231: A Phase III Clinical Trial Testing Bortezomib in Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia and Lymphoma. 35271306 Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2022 Jul 1 : 40(19)2106-2118 PMCID:PMC9242409 - Galardy PJ, Harker-Murray P, Horton TM, Jaju AI, Lam A, Messinger YH, Miles RR, Okada M, Patel SI, Schafer ES, Schechter T, Singh N, Steele AC, Sulis ML, Vargas SL, Winter SS, Wood C, Zweidler-McKay P, Bollard CM, Loh ML, Hunger SP, Raetz EAChildren's Oncology Group Trial AALL1231: A Phase III Clinical Trial Testing Bortezomib in Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia and Lymphoma. 35271306 Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2022 Jul 1 : 40(19)2106-2118 PMCID:PMC9242409 Barthe Chonghaile TN, Burns M, Stevenson KE, Devidas M, Loh ML, Hunger SP, Wood B, Silverman LB, Teachey DT, Meijerink JP, Letai A, Gutierrez in Chonghaile TN, Burns M, Stevenson KE, Devidas M, Loh ML, Hunger SP, Wood B, Silverman LB, Teachey DT, Meijerink JP, Letai A, Gutierrez in Chonghaile TN, Burns M, Stevenson KE, Devidas M, Loh ML, Hunger SP, Wood B, Silverman LB, Teachey DT, Meijerink JP, Letai A, Gutierrez in 35411095 June : 36(6)1499-1507 PMCID:PMC9177679 - S, Teachey DT, Chen Z, Rabin KR, Dunsmore KP, Larsen EC, Maloney KW, Mattano LA Jr, SS, Carroll AJ, Wood BL, Carroll ML, Hunger SP, Devidas MSex-based disparities in outcome in pediatric acute lymphoblastic leukemia: a Children's Oncology Group report. 35201611 Cancer, PMCID:PMC9007837 - Guest EM, Kairalla JA, Hilden JM, Dreyer ZE, Carroll AJ, Heerema NA, Wang CY, Devidas M, Gore NJ, Carroll WL, EA, Borowitz M, Loh ML, Hunger SP, Brown PAOutstanding outcomes in infants with KMT2A-germline acute lymphoblastic leukemia treated with chemotherapy alone: results Children's Oncology Group Guest Kairalla JA, Hilden JM, Dreyer ZE, Carroll AJ, Heerema NA, Wang CY, Devidas M, Gore NJ, Carroll WL, EA, Borowitz M, Loh ML, Hunger SP, Brown PAOutstanding outcomes in infants with KMT2A-germline acute lymphoblastic leukemia treated with chemotherapy alone: results Children's Oncology Group 107(5)1205-1208 PMCID:PMC9052896 Teachey DT, Chen Z, Rabin KR, Dunsmore KP, Larsen EC, Maloney KW, Mattano LA Jr, SS, Carroll AJ, Wood BL, Carroll ML, Hunger SP, Devidas MSex-based disparities in outcome in pediatric acute lymphoblastic leukemia: a Children's Oncology Group report. 35201611 Cancer, 1 : 128(9)1863-1870 PMCID:PMC9007837 - Gupta S, Teachey DT, Chen Z, Rabin KR, Dunsmore KP, Larsen EC, Maloney KW, Mattano LA Jr, SS, Carroll AJ, Wood BL, Carroll ML, Hunger SP, Devidas MSex-based disparities in outcome in pediatric acute lymphoblastic leukemia: a Children's Oncology Group report. 35201611 Cancer, PMCID:PMC9007837 - Guest EM, Kairalla JA, Hilden JM, Dreyer ZE, Carroll AJ, Heerema NA, Wang CY, Devidas M, Gore NJ, Carroll WL, EA, Borowitz M, Loh ML, Hunger SP, Brown PAOutstanding outcomes in infants with KMT2A-germline acute lymphoblastic leukemia treated with chemotherapy alone: results Children's Oncology Group A, Schwalbe Dai Y, Zaka M, Fung KT, Bashton M, Lim H, Jones L, Karataraki N, Winterman E, Ashby C, Attarbaschi A, Bertrand Y, Bradtke J, Buldini B, Burke GA, Cazzaniga G, Gohring G, Groot-Kruseman Haferlach Plesa E, Sonneveld E, Strehl S, Van der Velden VH, Rand V, Hunger SP, Harrison CJ, Bacon CM, Van Delft FW, Loh ML, Moppett J, Vormoor J, Walker BA, Moorman AV, Russell LJMolecular characterisation and clinical outcome of IG-MYC A, Mikulasova A, Dai Y, Zaka M, Fung KT, Bashton M, Lim H, Jones L, Karataraki N, Winterman E, Ashby C, Attarbaschi A, Bertrand Y, Bradtke J, Buldini B, Burke GA, Cazzaniga G, Gohring G, Groot-Kruseman Haferlach Plesa E, Sonneveld E, Strehl S, Van der Velden VH, Rand V, Hunger SP, Harrison CJ, Bacon CM, Van Delft FW, Loh ML, Moppett J, Vormoor J, Walker BA, Moorman AV, Russell LJMolecular characterisation and clinical outcome of IG-MYC A, Mikulasova A, Dai Y, Zaka M, Fung KT, Bashton M, Lim H, Jones L, Karataraki N, Winterman E, Ashby C, Attarbaschi A, Bertrand Y, Bradtke J, Buldini B, Burke GA, Cazzaniga G, Gohring G, Groot-Kruseman Haferlach Plesa E, Sonneveld E, Strehl S, Van der Velden VH, Rand V, Hunger SP, Harrison CJ, Bacon CM, Van Delft FW, Loh ML, Moppett J, Vormoor J, Walker BA, Moorman AV, Russell LJMolecular characterisation and clinical outcome of IG-MYC S, Schrappe M, Baruchel A, Biondi A, Borowitz M, Campbell M, Cario G, Cazzaniga G, Escherich G, Harrison CJ, Heyman M, Hunger SP, Kiss C, Liu HC, Locatelli F, Loh ML, Manabe A, Mann G, Pieters Pui CH, Rives S, K, Silverman LB, J, Vora Brown PRemission, treatment failure, and relapse in pediatric ALL: an international consensus of the Ponte-di-Legno Consortium. 34192312 Blood, 2022 Mar 24 : 139(12)1785-1793 PMCID:PMC8952186 Buchmann S, Schrappe M, Baruchel A, Biondi Borowitz M, Campbell M, Cario G, Cazzaniga G, Escherich G, Harrison CJ, Heyman M, Hunger SP, Kiss C, Liu HC, Locatelli F, Loh ML, Manabe A, Mann G, Pieters Pui CH, Rives S, K, Silverman LB, J, Vora Brown PRemission, treatment failure, and relapse in pediatric ALL: an international consensus of the Ponte-di-Legno Consortium. 34192312 Blood, 2022 Mar 24 : 139(12)1785-1793 PMCID:PMC8952186 - O'Brien MM, Ji L, Shah NN, Rheingold SR, Bhojwani D, Yuan CM, Xu X, Yi JS, Harris AC, Brown PA, Borowitz MJ, Militano O, Devidas M, Loh MLPhase II Trial of Inotuzumab Ozogamicin in Children and Adolescents Relapsed or Lymphoblastic Leukemia: Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2022 Mar 20 : 40(9)956-967 PMCID:PMC8937013 - O'Brien MM, Ji L, Shah NN, Rheingold SR, Bhojwani D, Yuan CM, Xu X, Yi JS, Harris AC, Brown PA, Borowitz MJ, Militano O, Devidas M, Loh MLPhase II Trial of Inotuzumab Ozogamicin in Children and Adolescents Relapsed or Lymphoblastic Leukemia: Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2022 Mar 20 : 40(9)956-967 PMCID:PMC8937013 NJ, Carroll WL, Hunger SP, Loh ML, Larsen ECOutcomes in adolescent and young adult patients (16 to 30 years) compared to younger patients treated for high-risk B-lymphoblastic leukemia: report from Children's Oncology PMCID:PMC9014378 - Lee SHR, Antillon-Klussmann F, Pei D, Yang W, Roberts KG, Li Z, Devidas M, Yang W, Najera C, Lin HP, Tan AM, Ariffin H, Cheng C, Evans WE, Hunger SP, Jeha S, Mullighan CG, Loh ML, Yeoh AEJ, Pui CH, Yang JJAssociation of Genetic Ancestry With the Molecular Subtypes and Prognosis of Childhood Acute Lymphoblastic Leukemia. 35084434 JAMA - Lee SHR, Antillon-Klussmann F, Pei D, Yang W, Roberts KG, Li Z, Devidas M, Yang W, Najera C, Lin HP, Tan AM, Ariffin H, Cheng C, Evans WE, Hunger SP, Jeha S, Mullighan CG, Loh ML, Yeoh AEJ, Pui CH, Yang JJAssociation of Genetic Ancestry With the Molecular Subtypes and Prognosis of Childhood Acute Lymphoblastic Leukemia. 35084434 JAMA NJ, Carroll WL, Hunger SP, Loh ML, Larsen ECOutcomes in adolescent and young adult patients (16 to 30 years) compared to younger patients treated for high-risk B-lymphoblastic leukemia: report from Children's Oncology PMCID:PMC9014378 - Lee SHR, Antillon-Klussmann F, Pei D, Yang W, Roberts KG, Li Z, Devidas M, Yang W, Najera C, Lin HP, Tan AM, Ariffin H, Cheng C, Evans WE, Hunger SP, Jeha S, Mullighan CG, Loh ML, Yeoh AEJ, Pui CH, Yang JJAssociation of Genetic Ancestry With the Molecular Subtypes and Prognosis of Childhood Acute Lymphoblastic Leukemia. 35084434 JAMA oncology, 2022 Mar 1 : 8(3)354-363 PMCID:PMC8796058 - Yang H, Zhang H, Luan Y, Liu T, Yang W, Roberts KG, Qian MX, Zhang B, Yang W, Perez-Andreu V, Xu J, Iyyanki S, Kuang D, Stasiak LA, Reshmi SC, Gastier-Foster J, Smith C, Pui SP, Platanias LC, Relling MV, Mullighan CG, Loh ML, Yue F, Yang JJNoncoding genetic variation in GATA3 increases acute lymphoblastic leukemia risk through local and global changes in chromatin conformation. 35115686 Nature genetics, 2022 Feb. : 54(2)170-179 PMCID:PMC9794680 - Yang H, Zhang H, Luan Y, Liu T, Yang W, Roberts KG, Qian MX, Zhang B, Yang W, Perez-Andreu V, Xu J, Iyyanki S, Kuang D, Stasiak LA, Reshmi SC, Gastier-Foster J, Smith C, Pui SP, Platanias LC, Relling MV, Mullighan CG, Loh ML, Yue F, Yang JJNoncoding genetic variation in GATA3 increases acute lymphoblastic leukemia risk through local and global changes in chromatin conformation. 35115686 Nature genetics, 2022 Feb. : 54(2)170-179 PMCID:PMC9794680 - Yang H, Zhang H, Luan Y, Liu T, Yang W, Roberts KG, Qian MX, Zhang B, Yang W, Perez-Andreu V, Xu J, Iyyanki S, Kuang D, Stasiak LA, Reshmi SC, Gastier-Foster J, Smith C, Pui SP, Platanias LC, Relling MV, Mullighan CG, Loh ML, Yue F, Yang JJNoncoding genetic variation in GATA3 increases acute lymphoblastic leukemia risk through local and global changes in chromatin conformation. 35115686 Nature genetics, 2022 Feb. : 54(2)170-179 PMCID:PMC9794680 - Yan Y, Dong L, Chen C, Bunting KD, Li Q, Stieglitz E, Loh ML, Qu CKJMML tumor cells disrupt normal hematopoietic stem cells by imposing inflammatory stress through overproduction of IL-1. 34555844 Blood advances, 2022 Jan 11 : 6(1)200-206 PMCID:PMC8753218 - Yan Y, Dong L, Chen C, Bunting KD, Li Q, Stieglitz E, Loh ML, Qu CKJMML tumor cells disrupt normal hematopoietic stem cells by imposing inflammatory stress through overproduction of IL-1. 34555844 Blood advances, 2022 Jan 11 : 6(1)200-206 PMCID:PMC8753218 - Yan Y, Dong L, Chen C, Bunting KD, Li Q, Stieglitz E, Loh ML, Qu CKJMML tumor cells disrupt normal hematopoietic stem cells by imposing inflammatory stress through overproduction of IL-1. 34555844 Blood advances, 2022 Jan 11 : 6(1)200-206 PMCID:PMC8753218 - Hecht A, Meyer JA, Behnert A, Wong E, Chehab F, Olshen A, Hechmer A, Aftandilian C, Bhat SW, M, Frangoul H, Han JH, ML, Narendran A, Oshrine B, Schultz ML, Van D, Tasian SK, Hofmann WK, Loh ML, Stieglitz EMolecular 2022 Jan 1 : 107(1)178-186 PMCID:PMC8719097 - Hecht A, Meyer JA, Behnert A, Wong E, Chehab F, Olshen A, Hechmer A, Aftandilian C, Bhat SW, M, Frangoul H, Han JH, ML, Narendran A, Oshrine B, Schultz ML, Van D, Tasian SK, Hofmann WK, Loh ML, Stieglitz EMolecular J, Parsa JY, Hechmer A, Loh ML, Olshen A, de Smith AJ, Stieglitz EExploring the genetic and epigenetic origins of juvenile myelomonocytic leukemia using newborn screening samples. 34183765 Leukemia, 2022 Jan. : 36(1)279-282 PMCID:PMC8720242 - Behnert J, Parsa JY, Hechmer A, Loh ML, Olshen A, de Smith AJ, Stieglitz EExploring the genetic and epigenetic origins of juvenile myelomonocytic leukemia using newborn screening samples. 34183765 Leukemia, 2022 Jan. : 36(1)279-282 PMCID:PMC8720242 - Kitazawa H, Okuno Y, Muramatsu H, Aoki K, Murakami N, Wakamatsu M, Suzuki K, Narita K, Kataoka S, Ichikawa D, Hamada M, Taniguchi R, Kawashima N, Nishikawa E, Narita A, Nishio N, Hama A, Loh ML, Stieglitz E, Kojima S, Takahashi YSimple and robust methylation test for risk stratification of patients with juvenile myelomonocytic leukemia. 34580726 Blood advances, 2021 Dec 28 : 5(24)5507-5518 PMCID:PMC8714717 - Kitazawa H, Okuno Y, Muramatsu H, Aoki K, Murakami N, Wakamatsu M, Suzuki K, Narita K, Kataoka S, Ichikawa D, Hamada M, Taniguchi R, Kawashima N, Nishikawa E, Narita A, Nishio N, Hama A, Loh ML, Stieglitz E, Kojima S, Takahashi YSimple and robust methylation test for risk stratification of patients with juvenile myelomonocytic leukemia. 34580726 Blood advances, 2021 Dec 28 : 5(24)5507-5518 PMCID:PMC8714717 - Kitazawa H, Okuno Y, Muramatsu H, Aoki K, Murakami N, Wakamatsu M, Suzuki K, Narita K, Kataoka S, Ichikawa D, Hamada M, Taniguchi R, Kawashima N, Nishikawa E, Narita A, Nishio N, Hama A, Loh ML, Stieglitz E, Kojima S, Takahashi YSimple and robust methylation test for risk stratification of patients with juvenile myelomonocytic leukemia. 34580726 Blood advances, 2021 Dec 28 : 5(24)5507-5518 A, Dvorak CC, Stieglitz E, myelomonocytic leukemia in the molecular era: a clinician's guide to diagnosis, risk stratification, and treatment. 34525182 Blood advances, 2021 Nov 23 : 5(22)4783-4793 PMCID:PMC8759142 A, Dvorak CC, Stieglitz E, myelomonocytic leukemia in the molecular era: a clinician's guide to diagnosis, risk stratification, and treatment. 34525182 Blood advances, 2021 Nov 23 : 5(22)4783-4793 PMCID:PMC8759142 - Montefiori LE, Bendig S, Gu Z, Chen X, P\u00f6l\u00f6nen P, Ma X, Murison A, Zeng A, Garcia-Prat L, Dickerson K, Iacobucci I, Abdelhamed S, Hiltenbrand R, Mead PE, Mehr CM, Xu B, Cheng Z, Chang TC, Westover T, Ma J, Stengel A, Kimura S, Qu C, Valentine MB, Rashkovan M, Luger S, Litzow MR, Rowe JM, den Boer ML, Wang V, Yin J, Kornblau SM, Hunger SP, Loh ML, Pui CH, Yang W, Crews KR, Roberts KG, Yang JJ, Relling MV, Evans WE, Stock W, Paietta EM, Ferrando AA, Zhang J, Kern W, Haferlach T, Wu G, Dick JE, Klco JM, Haferlach CGEnhancer Hijacking Lineage-Ambiguous Stem Leukemia. 34103329 Cancer 2021 Nov. : 11(11)2846-2867 PMCID:PMC8563395 - Montefiori LE, Bendig S, Gu Z, Chen X, P\u00f6l\u00f6nen P, Ma X, Murison A, Zeng A, Garcia-Prat L, Dickerson K, Iacobucci I, Abdelhamed S, Hiltenbrand R, Mead PE, Mehr CM, Xu B, Cheng Z, Chang TC, Westover T, Ma J, Stengel A, Kimura S, Qu C, Valentine MB, Rashkovan M, Luger S, Litzow MR, Rowe JM, den Boer ML, Wang V, Yin J, Kornblau SM, Hunger SP, Loh ML, Pui CH, Yang W, Crews KR, Roberts KG, Yang JJ, Relling MV, Evans WE, Stock W, Paietta EM, Ferrando AA, Zhang J, Kern W, Haferlach T, Wu G, Dick JE, Klco JM, Haferlach CGEnhancer Hijacking Lineage-Ambiguous Stem Leukemia. 34103329 Cancer discovery, 2021 Nov. : 11(11)2846-2867 PMCID:PMC8563395 - Leonard Wolf D, Lenz MM, Tyner JW, Chang BHAurora A kinase as a target for therapy in TCF3-HLF rearranged acute lymphoblastic leukemia. 34233449 Haematologica, 2021 Nov Degnin D, Lenz MM, Tyner JW, Chang BHAurora A kinase as a target for therapy in TCF3-HLF rearranged acute lymphoblastic leukemia. 34233449 Haematologica, 2021 Nov ER, Ohki ML, Nor\u00e9n-Nystr\u00f6m U, Pastorczak A, Shih LY, Zaliova M, OA, Harrison CJ, Moorman outcomes of B-ALL with ZNF384 rearrangements: a retrospective analysis by the Ponte di Legno Childhood ALL Working Group. 33692463 Leukemia, 2021 Nov. : 35(11)3272-3277 PMCID:PMC8550960 - Hirabayashi ER, ML, Nor\u00e9n-Nystr\u00f6m U, Pastorczak A, Shih LY, Zaliova M, OA, Harrison CJ, Moorman outcomes of B-ALL with ZNF384 rearrangements: a retrospective analysis by the Ponte di Legno Childhood ALL Working Group. 33692463 Leukemia, 2021 Nov. : 35(11)3272-3277 PMCID:PMC8550960 - Mangum DS, Maese LD, Gardiner JD, Downie JM, Pei Cheng C, Gleason A, Luo M, Pui CH, Aplenc R, Hunger SP, Loh M, Greaves M, Trede N, Raetz E, Frazer JK, Mullighan CG, Engel ME, Miles RR, Rabin KR, Schiffman JDAssociation of Combined Focal 22q11.22 Deletion and IKZF1 Alterations With Outcomes in Childhood Acute Lymphoblastic Leukemia. 34410295 oncology, 2021 Oct 1 Maese LD, Gardiner JD, Downie JM, Pei Cheng C, Gleason A, Luo M, Pui CH, Aplenc R, Hunger SP, Loh M, Greaves M, Trede N, Raetz E, Frazer JK, Mullighan CG, Engel ME, Miles RR, Rabin KR, Schiffman JDAssociation of Combined Focal 22q11.22 Deletion and IKZF1 Alterations With Outcomes in Childhood Acute Lymphoblastic Leukemia. 34410295 JAMA oncology, 2021 Oct E, Kogan SC, Loh ML, Braun BSNf1 and Sh2b3 mutations cooperate in vivo in a mouse model of juvenile myelomonocytic leukemia. 34464969 Blood advances, 2021 Sep 28 : 5(18)3587-3591 PMCID:PMC8945579 - Morales CE, Stieglitz E, Kogan SC, Loh ML, Braun BSNf1 and Sh2b3 mutations cooperate in vivo in a mouse model of juvenile myelomonocytic leukemia. 34464969 Blood advances, 2021 Sep 28 : 5(18)3587-3591 PMCID:PMC8945579 - Liu Y, Yang W, Smith CA, Cheng C, Karol SE, Larsen EC, Winick N, Carroll WL, Loh ML, Raetz EA, Hunger SP, Winter SS, Dunsmore KP, Devidas M, Yang JJ, Evans WE, Jeha Inaba H, Relling MVClass II therapeutics, 2021 Sept. : 110(3)794-802 PMCID:PMC8790808 - Liu Y, Yang W, Smith CA, Cheng C, Karol SE, Larsen EC, Winick N, Carroll WL, Loh ML, Raetz EA, Hunger SP, Winter SS, Dunsmore KP, Devidas M, Yang JJ, Evans WE, Jeha Inaba H, Relling MVClass II AV, Braun BS, Sali A, Mullighan CG, Shah NP, Dai Y, Devidas M, Roberts KG, Smith CC, Loh MLThe EBF1-PDGFRB T681I mutation is highly resistant to imatinib and dasatinib in vitro and detectable in clinical samples prior to treatment. 33626861 Haematologica, 2021 Aug 1 : Stecula AV, Braun BS, Sali A, Mullighan CG, Shah NP, Dai Y, Devidas M, Roberts KG, Smith CC, Loh MLThe EBF1-PDGFRB T681I mutation is highly resistant to imatinib and dasatinib in vitro and detectable in clinical samples prior to treatment. 33626861 Haematologica, 2021 Aug 1 : Hayashi RJ, Winter SS, Hunger SP, Carroll WL, Loh ML, Devidas M, Gross TG, Bollard CM, Perkins SL, Miles RRGenomic and clinical characterization of early T-cell precursor lymphoblastic lymphoma. 34297047 Blood advances, 2021 Jul X, Paxton Hayashi RJ, Winter SS, Hunger SP, Carroll WL, Loh ML, Devidas M, Gross TG, Bollard CM, Perkins SL, Miles RRGenomic and clinical characterization of early T-cell precursor lymphoblastic lymphoma. 34297047 Blood advances, 2021 Jul 27 : 5(14)2890-2900 Lee SHR, Qian M, Yang W, Diedrich JD, Raetz E, Yang W, Dong Q, Devidas M, Pei D, Yeoh A, Cheng C, Pui CH, Evans WE, Mullighan CG, Hunger SP, Savic D, Relling MV, Loh ML, Yang JJGenome-Wide Association Study of Susceptibility Loci for TCF3-PBX1 Acute Lymphoblastic Leukemia in Children. 32882024 Journal of the National Cancer Institute, 2021 Jul 1 : 113(7)933-937 PMCID:PMC8487647 - Lee SHR, Qian M, Yang W, Diedrich JD, Raetz E, Yang W, Dong Q, Devidas M, Pei D, Yeoh A, Cheng C, Pui CH, Evans WE, Mullighan CG, Hunger SP, Savic D, Relling MV, Loh ML, Yang JJGenome-Wide Association Study of Susceptibility Loci for TCF3-PBX1 Acute Lymphoblastic Leukemia in Children. 32882024 Journal of the National Cancer Institute, 2021 Jul 1 : 113(7)933-937 PMCID:PMC8487647 - Li Y, Yang W, Devidas M, Winter SS, Kesserwan C, Yang W, Dunsmore KP, Smith C, Qian M, Zhao X, Zhang R, Gastier-Foster JM, Raetz EA, Carroll T, Mullighan CG, Nichols KE, Evans WE, Pui CH, Hunger SP, Teachey DT, Relling MV, Loh ML, Yang JJGermline RUNX1 variation and predisposition to childhood acute lymphoblastic leukemia. 34166225 The Journal of clinical investigation, 2021 Jun 24 : 131(17) PMCID:PMC8409579 - Li Y, Yang W, Devidas M, Winter SS, Kesserwan C, Yang W, Dunsmore KP, Smith C, Qian M, Zhao X, Zhang R, Gastier-Foster JM, Raetz EA, Carroll T, Mullighan CG, Nichols KE, Evans WE, Pui CH, Hunger SP, Teachey DT, Relling MV, Loh ML, Yang JJGermline RUNX1 variation and predisposition to childhood acute lymphoblastic leukemia. 34166225 The Journal of clinical investigation, 2021 Jun 24 : 131(17) PMCID:PMC8409579 - Pikman Y, Tasian SK, Sulis ML, Stevenson K, Blonquist TM, Apsel Winger B, Cooper TM, Pauly M, Maloney Gennarini L, Adhav AA, Clinton CM, Ocasio-Martinez N, Gotti G, Li Y, Lin S, Imamovic WA, Garrido Ruiz Jacobson MP, Dharia NV, Su A, Robichaud AL, Saur Conway A, Tarlock K, Stieglitz E, Place AE, Puissant A, Hunger SP, Kim AS, Lindeman NI, Gore L, Janeway KA, Silverman LB, Tyner JW, Harris MH, Loh ML, Stegmaier KMatched Targeted Therapy for Pediatric Patients with Relapsed, Refractory, or High-Risk Leukemias: A Report from the LEAP Consortium. 33563661 Cancer discovery, 2021 June : 11(6)1424-1439 PMCID:PMC8178162 - Pikman Tasian SK, Sulis ML, Stevenson K, Blonquist TM, Apsel Winger B, Cooper TM, Pauly M, Maloney Gennarini L, Adhav AA, Clinton CM, Ocasio-Martinez N, Gotti G, Li Y, Lin S, Imamovic WA, Garrido Ruiz Jacobson MP, Dharia NV, Su A, Robichaud AL, Saur Conway A, Tarlock K, Stieglitz E, Place AE, Puissant A, Hunger SP, Kim AS, Lindeman NI, Gore L, Janeway KA, Silverman LB, Tyner JW, Harris MH, Loh ML, Stegmaier KMatched Targeted Therapy for Pediatric Patients with Relapsed, Refractory, or High-Risk Leukemias: A Report from the LEAP Consortium. 33563661 Cancer discovery, 2021 June : 11(6)1424-1439 PMCID:PMC8178162 - Mattano LA Jr, Devidas M, Maloney KW, Wang C, Friedmann Buckley AALL0331. 33739852 Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2021 May 10 : 39(14)1540-1552 PMCID:PMC8274747 - Mattano LA Jr, Devidas M, Maloney KW, Wang C, Friedmann Buckley AALL0331. 33739852 Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2021 May 10 : 39(14)1540-1552 PMCID:PMC8274747 - Brown PA, Kairalla JA, Hilden JM, Dreyer ZE, Carroll AJ, Heerema NA, Wang C, Devidas M, Gore ML, inhibitor lestaurtinib plus chemotherapy for newly diagnosed Children's B, Carroll AJ, Heerema NA, Relling MV, Hitzler J, Lane AR, Maloney KW, C, Bassal M, Carroll WL, Winick NJ, Raetz EA, Loh ML, Hunger SPExcellent Outcomes Vincristine and 33411585 Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2021 May 1 : 39(13)1437-1447 PMCID:PMC8274746 - Brown PA, Kairalla JA, Hilden JM, Dreyer ZE, Carroll AJ, Heerema NA, Wang C, Devidas M, Gore ML, inhibitor lestaurtinib plus chemotherapy for newly diagnosed Children's B, Carroll AJ, Heerema NA, Relling MV, Hitzler J, Lane AR, Maloney KW, C, Bassal M, Carroll WL, Winick NJ, Raetz EA, Loh ML, Hunger SPExcellent Outcomes Vincristine and 33411585 Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2021 May 1 : 39(13)1437-1447 PMCID:PMC8274746 - Brown PA, Kairalla JA, Hilden JM, Dreyer ZE, Carroll AJ, Heerema NA, Wang C, Devidas M, Gore inhibitor lestaurtinib plus Children's - Brown PA, Kairalla JA, Hilden JM, Dreyer ZE, Carroll AJ, Heerema NA, Wang C, Devidas M, Gore inhibitor lestaurtinib plus Children's Leukemia, : 35(5)1527 - Zhang H, Liu AP, Devidas M, Lee SH, Cao X, Pei D, Borowitz M, Wood B, Gastier-Foster JM, Dai Y, Raetz E, Larsen E, Winick N, Bowman WP, Karol S, Yang W, Martin PL, Carroll WL, Pui CH, Mullighan CG, Evans WE, Cheng C, Hunger SP, Relling MV, Loh ML, Yang JJAssociation of GATA3 Polymorphisms With Minimal Residual Disease and Relapse Risk in Childhood Acute Lymphoblastic Leukemia. 32894760 Journal of the National Cancer Institute, 2021 Apr 6 : 113(4)408-417 PMCID:PMC8680540 - Zhang H, Liu AP, Devidas M, Lee SH, Cao X, Pei D, Borowitz M, Wood B, Gastier-Foster JM, Dai Y, Raetz E, Larsen E, Winick N, Bowman WP, Karol S, Yang W, Martin PL, Carroll WL, Pui CH, Mullighan CG, Evans WE, Cheng C, Hunger SP, Relling MV, Loh ML, Yang JJAssociation of GATA3 Polymorphisms With Minimal Residual Disease and Relapse Risk in Childhood Acute Lymphoblastic Leukemia. 32894760 Journal of the National Cancer Institute, 2021 Apr 6 : 113(4)408-417 PMCID:PMC8680540 - Schwab C, Roberts K, Boer JM, G\u00f6hring G, Steinemann D, Vora A, Macartney C, Hough Thorn Z, Dillon R, Escherich G, Cazzaniga G, Schlegelberger B, Loh M, den Boer ML, Moorman AV, Harrison CJSSBP2-CSF1R is a recurrent fusion in B-lineage acute lymphoblastic leukemia with diverse genetic presentation and variable outcome. 33197935 Blood, 2021 Apr 1 : 137(13)1835-1838 - Rau RE, Dai Y, M, EA, Loh ML, Wood BL, Borowitz MJPrognostic impact of minimal residual disease at the end of consolidation in NCI standard-risk B-lymphoblastic leukemia: A report from the Children's Oncology Group. Pediatric blood & cancer, 2021 April : 68(4)e28929 PMCID:PMC8808711 - Rau RE, Dai EA, Loh ML, Wood BL, Borowitz MJPrognostic impact of minimal residual disease at the end of consolidation in NCI standard-risk B-lymphoblastic leukemia: A report from the Children's Oncology Group. Pediatric blood & cancer, 2021 April : 68(4)e28929 PMCID:PMC8808711 - Schwab C, Roberts K, Boer JM, G\u00f6hring G, Steinemann D, Vora A, Macartney C, Hough Thorn Z, Dillon R, Escherich G, Cazzaniga G, Schlegelberger B, Loh M, den Boer ML, Moorman AV, Harrison CJSSBP2-CSF1R is a recurrent fusion in B-lineage acute lymphoblastic leukemia with diverse genetic presentation and variable outcome. 33197935 Blood, 2021 Apr 1 : 137(13)1835-1838 - Yang W, Devidas M, Liu Y, Smith C, Dai Y, Winick N, Hunger SP, Loh ML, Raetz EA, Larsen EC, Carroll WL, of acute lymphoblastic leukemia and general populations. 33106839 Blood, 2021 Mar 18 : 137(11)1550-1552 PMCID:PMC7976510 - Yang W, Devidas M, Liu Y, Smith C, Dai Y, Winick N, Hunger SP, Loh ML, Raetz EA, Larsen EC, Carroll WL, of acute lymphoblastic leukemia and general populations. 33106839 Blood, 2021 Mar Loocke Roels J, Peirs S, Pieters T, F, DL, LC, Risseeuw Calenbergh S, Takarada T, Y, van Delft FW, Merkley SD, Chigaev A, Sklar LA, Mullighan CG, Loh ML, Winter SS, Hunger SP, Goossens S, Castillo EF, Ornatowski W, Van Vlierberghe P, Matlawska-Wasowska KRUNX2 regulates leukemic cell metabolism and chemotaxis in high-risk T cell acute lymphoblastic leukemia. 33555272 The Journal of clinical investigation, 2021 Mar : Loocke Roels J, Peirs S, Pieters T, F, DL, LC, Risseeuw Calenbergh S, Takarada T, Y, van Delft FW, Merkley SD, Chigaev A, Sklar LA, Mullighan CG, Loh ML, Winter SS, Hunger SP, Goossens S, Castillo EF, Ornatowski W, Van Vlierberghe P, Matlawska-Wasowska KRUNX2 regulates leukemic cell metabolism and chemotaxis in high-risk T cell acute lymphoblastic leukemia. 33555272 The Journal of clinical investigation, 2021 Mar 15 : 131(6) PMCID:PMC7954605 - Brown PA, Ji L, Xu X, Devidas M, Hogan LE, Borowitz MJ, Raetz EA, Zugmaier SA, Gore L, Whitlock JA, Pulsipher MA, Hunger SP, Loh MLEffect of Postreinduction Therapy Consolidation With Blinatumomab vs Chemotherapy on Disease-Free Survival in Children, Adolescents, and Young Adults With First Relapse of B-Cell Acute Lymphoblastic Leukemia: A Mar 2 : 325(9)833-842 PMCID:PMC7926290 - Brown PA, Ji L, Xu X, Devidas M, Hogan LE, Borowitz MJ, Raetz EA, Zugmaier SA, Gore L, Whitlock JA, Pulsipher MA, Hunger SP, Loh MLEffect of Postreinduction Therapy Consolidation With Blinatumomab vs Chemotherapy on Disease-Free Survival in Children, Adolescents, and Young Adults With First Relapse of B-Cell Acute Lymphoblastic Leukemia: A Laumann K, Luger SM, Liedtke M, Devidas M, Chen J, Claxton D, Coffan K, Tallman MS, Appelbaum FR, Erba Stone RM, Hunger SP, McNeer JL, Loh ML, Raetz E, Winick N, Carroll W, Larson RA, Stock WComparison of CALGB 10403 (Alliance) and COG AALL0232 toxicity results in young adults with acute lymphoblastic leukemia. 33496745 Blood advances, 2021 Jan 26 : 5(2)504-512 Laumann K, Luger SM, Liedtke M, Devidas M, Chen J, Claxton D, Coffan K, Tallman MS, Appelbaum FR, Erba Stone RM, Hunger SP, McNeer JL, Loh ML, Raetz E, Winick N, Carroll W, Larson RA, Stock WComparison of CALGB 10403 (Alliance) and COG AALL0232 toxicity results in young adults with acute lymphoblastic leukemia. 33496745 Blood advances, 2021 Jan 26 : 5(2)504-512 PMCID:PMC7839367 - Nishii R, Baskin-Doerfler R, Yang W, Oak N, Zhao X, Yang W, Hoshitsuki K, Bloom M, Verbist K, Burns M, Li Z, Lin TN, Qian M, Moriyama T, Gastier-Foster Metzger ML, Klco JM, Hunger SP, Newman S, Wu G, Loh ML, Nichols KE, Yang JJMolecular basis of ETV6-mediated predisposition to childhood acute lymphoblastic leukemia. Blood, 21 : 137(3)364-373 PMCID:PMC7819760 - Nishii R, Baskin-Doerfler R, Yang W, Oak N, Zhao X, Yang W, Hoshitsuki K, Bloom M, Verbist K, Burns M, Li Z, Lin TN, Qian M, Moriyama T, Gastier-Foster Metzger ML, Klco JM, Hunger SP, Newman S, Wu G, Loh ML, Nichols KE, Yang JJMolecular basis of ETV6-mediated predisposition to childhood acute lymphoblastic leukemia. Blood, 2021 Jan 21 : 137(3)364-373 PMCID:PMC7819760 - Teachey DT, Hunger SP, Loh MLOptimizing therapy in the modern age: differences in length of maintenance therapy in acute lymphoblastic leukemia. 32877503 Blood, 2021 Jan 14 : 137(2)168-177 PMCID:PMC7820874 - Teachey DT, Hunger SP, Loh MLOptimizing therapy in the modern age: differences in length of maintenance therapy in acute lymphoblastic leukemia. 32877503 Blood, 2021 Jan 14 : 137(2)168-177 PMCID:PMC7820874 Sch\u00f6nung M, Meyer J, N\u00f6llke P, Olshen Hartmann M, Murakami N, Wakamatsu M, Okuno Y, Plass C, Loh ML, Niemeyer CM, Muramatsu H, Flotho C, Stieglitz E, Lipka DBInternational Consensus Definition of DNA Methylation Subgroups in Juvenile Myelomonocytic Leukemia. 33139265 Clinical cancer research : an official journal of the American Association for Cancer Research, 2021 Jan 1 : 27(1)158-168 PMCID:PMC7785676 - Sch\u00f6nung M, Meyer J, N\u00f6llke P, Olshen Hartmann M, Murakami N, Wakamatsu M, Okuno Y, Plass C, Loh ML, Niemeyer CM, Muramatsu H, Flotho C, Stieglitz E, Lipka DBInternational Consensus Definition of DNA Methylation Subgroups in Juvenile Myelomonocytic Leukemia. 33139265 Clinical cancer research : an official journal of the American Association for Cancer Research, 2021 Jan 1 : 27(1)158-168 PMCID:PMC7785676 - den Boer ML, Cario G, Moorman AV, JM, de Groot-Kruseman HA, Fiocco Escherich Imamura A, Sutton R, L, Kiyokawa N, Schrappe M, Roberts KG, Mullighan A, Attarbaschi A, Zaliova M, Elitzur S, Cazzaniga G, Biondi A, Loh ML, Pieters R, Ponte di Legno Childhood ALL Working GroupOutcomes of paediatric patients with B-cell retrospective, Haematology, 2021 Jan. : 8(1)e55-e66 PMCID:PMC9709453 - den Boer ML, G, Moorman AV, JM, de Groot-Kruseman HA, Fiocco Escherich Imamura A, Sutton R, L, Kiyokawa N, Schrappe M, Roberts KG, Mullighan A, Attarbaschi A, Zaliova M, Elitzur S, Cazzaniga G, Biondi A, Loh ML, Pieters R, Ponte di Legno Childhood ALL Working GroupOutcomes of paediatric patients with B-cell retrospective, Jan. 8(1)e55-e66 Bhatla T, Sethia G, Narang S, Choi JH, Ma X, Yang JJ, Kelly S, Raetz E, Harvey RC, Willman C, Loh ML, Hunger SP, Brown PA, Getz KM, Meydan C, Mason CE, Tsirigos A, Carroll WLEvolution of the Epigenetic Landscape in Childhood B Acute Lymphoblastic Leukemia and Its Role in Drug Resistance. 33067268 Cancer research, 2020 Dec 1 : 80(23)5189-5202 PMCID:PMC8647946 - Saint Fleur-Lominy S, Evensen NA, Bhatla T, Sethia G, Narang S, Choi JH, Ma X, Yang JJ, Kelly S, Raetz E, Harvey RC, Willman C, Loh ML, Hunger SP, Brown PA, Getz KM, Meydan C, Mason CE, Tsirigos A, Carroll WLEvolution of the Epigenetic Landscape in Childhood B Acute Lymphoblastic Leukemia and Its Role in Drug Resistance. 33067268 Cancer research, 2020 Dec 1 : 80(23)5189-5202 PMCID:PMC8647946 - Oshima K, Zhao J, P\u00e9rez-Dur\u00e1n P, Brown JA, Pati\u00f1o-Galindo JA, Chu T, Quinn A, Gunning T, Belver L, Ambesi-Impiombato A, Tosello V, Wang Z, Sulis ML, Kato M, Koh K, Paganin M, Basso G, Balbin M, Nicolas JM, ML, Paietta E, Tallman M, Minden MD, Meijerink J, Rabadan R, Ferrando AMutational and functional genetics mapping of chemotherapy resistance mechanisms in relapsed acute lymphoblastic leukemia. 33796864 Nature cancer, 2020 Nov. : 1(11)1113-1127 PMCID:PMC8011577 - Oshima K, Zhao J, P\u00e9rez-Dur\u00e1n P, Brown JA, Pati\u00f1o-Galindo JA, Chu T, Quinn A, Gunning T, Belver L, Ambesi-Impiombato A, Tosello V, Wang Z, Sulis ML, Kato M, Koh K, Paganin M, Basso G, Balbin M, Nicolas JM, ML, Paietta E, Tallman M, Minden MD, Meijerink J, Rabadan R, Ferrando AMutational and functional genetics mapping of chemotherapy resistance mechanisms in relapsed acute lymphoblastic leukemia. 33796864 Nature cancer, 2020 Nov. : 1(11)1113-1127 PMCID:PMC8011577 Dunsmore KP, Winter SS, Devidas M, Wood Eisenberg SPChildren's Oncology Group AALL0434: A Phase III Randomized Clinical Trial Testing Nelarabine in Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia. 32813610 Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2020 Oct 1 : 38(28)3282-3293 PMCID:PMC7526719 - Dunsmore KP, Winter SS, Devidas M, Wood Eisenberg SPChildren's Oncology Group AALL0434: A Phase III Randomized Clinical Trial Testing Nelarabine in Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia. 32813610 Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2020 Oct 1 : 38(28)3282-3293 PMCID:PMC7526719 - Hayashi RJ, Z, Wood BL, Hermiston ML, Teachey DT, Perkins SL, Miles RR, Raetz EA, Loh ML, Winick NJ, Carroll WL, Hunger SP, Lim MS, Gross TG, Bollard CMSuccessful Outcomes of Newly Diagnosed T Lymphoblastic Lymphoma: Results From Children's Oncology Group AALL0434. 32552472 Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2020 Sep 10 : 38(26)3062-3070 PMCID:PMC7479761 - Hayashi RJ, Z, Wood BL, Hermiston ML, Teachey DT, Perkins SL, Miles RR, Raetz EA, Loh ML, Winick NJ, Carroll WL, Hunger SP, Lim MS, Gross TG, Bollard CMSuccessful Outcomes of Newly Diagnosed T Lymphoblastic Lymphoma: Results From Children's Oncology Group AALL0434. 32552472 Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2020 Sep 10 : 38(26)3062-3070 PMCID:PMC7479761 - Salzer WL, Burke MJ, Devidas M, Hardy KK, Kairalla JA, Gore L, Hilden JM, Larsen E, Rabin KR, Zweidler-McKay PA, Borowitz MJ, N, WL, Raetz EA, Loh ML, Hunger Intrathecal Triple Study AALL1131. 32496902 Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2020 Aug 10 : 38(23)2628-2638 PMCID:PMC7402996 - Salzer WL, Burke MJ, Devidas M, Hardy KK, Kairalla JA, Gore L, Hilden JM, Larsen E, Rabin KR, Zweidler-McKay PA, Borowitz MJ, N, WL, Raetz EA, Loh ML, Hunger Intrathecal Triple Study AALL1131. 32496902 Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2020 Aug 10 : 38(23)2628-2638 PMCID:PMC7402996 - Pierro J, J, Narang S, Sethia G, Saint Fleur-Lominy Chowdhury A, Qualls A, Fay H, Kilberg HL, Moriyama T, Fuller TJ, Teachey DT, Schmiegelow K, Yang JJ, Loh ML, Brown PA, Zhang J, Ma X, Tsirigos A, Evensen NA, Carroll WLThe NSD2 p.E1099K Mutation Is Enriched at Relapse and Confers Drug Resistance in a Cell Context-Dependent Manner in Pediatric Acute Lymphoblastic Leukemia. 32332049 Molecular cancer research : MCR, 2020 Aug. : 18(8)1153-1165 PMCID:PMC7415532 - Pierro J, Narang S, Sethia G, Saint Fleur-Lominy Chowdhury A, Qualls A, Fay H, Kilberg HL, Moriyama T, Fuller TJ, Teachey DT, Schmiegelow K, Yang JJ, Loh ML, Brown PA, Zhang J, Ma X, Tsirigos A, Evensen NA, Carroll WLThe NSD2 p.E1099K Mutation Is Enriched at Relapse and Confers Drug Resistance in a Cell Context-Dependent Manner in Pediatric Acute Lymphoblastic Leukemia. 32332049 Molecular cancer research : MCR, 2020 Aug. : 18(8)1153-1165 PMCID:PMC7415532 - Sullivan M, Bouffet E, Rodriguez-Galindo C, Luna-Fineman S, Khan MS, Kearns P, Hawkins DS, Challinor J, Morrissey L, Fuchs J, Marcus K, Balduzzi A, Basset-Salom L, Caniza M, Baker JN, Kebudi R, L, Sullivan R, Pritchard-Jones K, Contributing AuthorsThe COVID-19 pandemic: A rapid global response for children with cancer from SIOP, COG, SIOP-E, SIOP-PODC, IPSO, PROS, CCI, and St Jude Global. 32400924 Pediatric blood & cancer, 2020 July : 67(7)e28409 PMCID:PMC7235469 - Sullivan M, Bouffet E, Rodriguez-Galindo C, Luna-Fineman S, Khan MS, Kearns P, Hawkins DS, Challinor J, Morrissey L, Fuchs J, Marcus K, Balduzzi A, Basset-Salom L, Caniza M, Baker JN, Kebudi R, L, Sullivan R, Pritchard-Jones K, Contributing AuthorsThe COVID-19 pandemic: A rapid global response for children with cancer from SIOP, COG, SIOP-E, SIOP-PODC, IPSO, PROS, CCI, and St Jude Global. 32400924 Pediatric blood & cancer, 2020 July : 67(7)e28409 PMCID:PMC7235469 - Gupta S, Wang C, Raetz Salzer WL, LA Jr, Carroll WL, Winick NJ, Hunger SP, Loh ML, Devidas MImpact of Asparaginase Discontinuation on Outcome in Childhood Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group. 32275469 Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2020 Jun 10 : 38(17)1897-1905 PMCID:PMC7280050 - Gupta S, Wang C, Raetz Salzer WL, LA Jr, Carroll WL, Winick NJ, Hunger SP, Loh ML, Devidas MImpact of Asparaginase Discontinuation on Outcome in Childhood Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group. 32275469 Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2020 Jun 10 : 38(17)1897-1905 PMCID:PMC7280050 Esposito D, Hernandez ER, Legius E, Loh ML, Martin S, Morrison DK, Rauen KA, Wolters PL, Zand D, McCormick F, Savage SA, BC, Yohe MEAdvancing RAS/RASopathy therapies: An NCI-sponsored collaboration for the study of RASopathies. 31913576 American journal of medical genetics. Part A, 2020 April : 182(4)866-876 PMCID:PMC7456498 - Gross Esposito D, Hernandez ER, Legius E, Loh ML, Martin S, Morrison DK, Rauen KA, Wolters PL, Zand D, McCormick F, Savage SA, BC, Yohe MEAdvancing RAS/RASopathy therapies: An NCI-sponsored collaboration for the study of RASopathies. 31913576 American journal of medical genetics. Part A, 2020 April : 182(4)866-876 PMCID:PMC7456498 - Maloney KW, Devidas M, Wang C, Mattano MJ, Carroll NA, DT, Stork LC, EA, Wood B, Carroll AALL0331. 31825704 Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2020 Feb 20 : 38(6)602-612 PMCID:PMC7030893 - Maloney KW, Devidas M, Wang C, Mattano MJ, Carroll NA, DT, Stork LC, EA, Wood B, Carroll AALL0331. 31825704 Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2020 Feb 20 : 38(6)602-612 PMCID:PMC7030893 - Chao AK, Meyer JA, Lee AG, Hecht A, Tarver T, Van Ziffle J, Koegel AK, Golden C, Braun BS, Sweet-Cordero EA, CC, Dvorak CC, Loh ML, Stieglitz JMML: a novel CCDC88C-FLT3 fusion responsive to sorafenib identified by RNA sequencing. 31511612 Leukemia, 2020 Feb. : 34(2)662-666 PMCID:PMC6995757 - Chao AK, Meyer JA, Lee AG, Hecht A, Tarver T, Van Ziffle J, Koegel AK, Golden C, Braun BS, Sweet-Cordero EA, CC, Dvorak CC, Loh ML, Stieglitz JMML: a novel CCDC88C-FLT3 fusion responsive to sorafenib identified by RNA sequencing. 31511612 Leukemia, 2020 Feb. : SP, Carroll AJ 3rd, Heerema NA, Berman JN, Woods WG, Loh ML, Zweidler-McKay PA, Horan JT, Children's Oncology Group Acute Leukemia of Ambiguous Lineage Task ForceMixed-phenotype acute leukemia: A cohort and consensus research strategy from the Children's Oncology Group Acute Leukemia of Ambiguous Lineage Task Force. 31661160 Cancer, 2020 Feb 1 : 126(3)593-601 PMCID:PMC7489437 Alexander SP, Carroll AJ 3rd, Heerema NA, Berman JN, Woods WG, Loh ML, Zweidler-McKay PA, Horan JT, Children's Oncology Group Acute Leukemia of Ambiguous Lineage Task ForceMixed-phenotype acute leukemia: A cohort and consensus research strategy from the Children's Oncology Group Acute Leukemia of Ambiguous Lineage Task Force. 31661160 Cancer, 2020 Feb 1 : 126(3)593-601 PMCID:PMC7489437 - Qian M, Zhao X, Devidas M, Yang W, Gocho Y, Smith C, Gastier-Foster JM, Li Y, Xu H, Zhang S, Jeha S, Zhai X, Sanda T, Winter SS, Pui CH, Evans WE, Hunger SP, Mullighan CG, Relling MV, Loh ML, Yang JJGenome-Wide Association Study of Susceptibility Loci for T-Cell Acute Lymphoblastic Leukemia in Children. 30938820 Journal of the National Cancer Institute, 2019 Dec 1 : 111(12)1350-1357 PMCID:PMC6910193 - Vijayakrishnan J, Qian M, Studd JB, Yang W, Kinnersley B, Law PJ, Broderick P, Raetz EA, Allan J, Pui CH, Vora A, Evans WE, Moorman A, Yeoh A, Yang W, Li C, Bartram CR, Mullighan CG, Zimmerman M, Hunger SP, Schrappe M, Relling MV, Stanulla M, Loh ML, Houlston RS, Yang JJIdentification of four novel associations for B-cell acute lymphoblastic leukaemia risk. 31767839 Nature communications, 2019 Nov 25 : 10(1)5348 PMCID:PMC6877561 - Vijayakrishnan J, Qian M, Studd JB, Yang W, Kinnersley B, Law PJ, Broderick P, Raetz EA, Allan J, Pui CH, Vora A, Evans WE, Moorman A, Yeoh A, Yang W, Li C, Bartram CR, Mullighan CG, Zimmerman M, Hunger SP, Schrappe M, Relling MV, Stanulla M, Loh ML, Houlston RS, Yang JJIdentification of four novel associations for B-cell acute lymphoblastic leukaemia risk. 31767839 Nature communications, 2019 Nov 25 : 10(1)5348 PMCID:PMC6877561 - Hecht A, Meyer J, Chehab FF, White KL, Magruder K, Dvorak CC, Loh ML, Stieglitz EMolecular assessment of pretransplant chemotherapy in the treatment of juvenile myelomonocytic leukemia. 31347788 Pediatric blood & cancer, 2019 Nov. : 66(11)e27948 PMCID:PMC6754267 - Raetz EA, Loh ML, Devidas M, Maloney K, Mattano LA Jr, Larsen E, Carroll A, Heerema NA, Gastier-Foster JM, Wood B, Borowitz SP, Carroll WLImpact of corticosteroid pretreatment in pediatric patients with newly diagnosed B-lymphoblastic leukemia: a report from the Children's Oncology Group. 31004024 Haematologica, 2019 Nov. : 104(11)e517-e520 PMCID:PMC6821605 - Brown AL, de Smith AJ, Gant VU, Yang W, Scheurer ME, Walsh KM, Chernus JM, Kallsen Hansen Morimoto L, Kang AY, Smirnov I, J, Laverdi\u00e8re C, Sinnett D, Taub Hunger SP, Pui CH, Loh ML, Zwick ME, Metayer C, Ma X, Mueller BA, Sherman SL, Wiemels JL, Relling MV, Yang JJ, Lupo PJ, Rabin KRInherited genetic susceptibility to acute lymphoblastic leukemia in Down syndrome. 31350265 Blood, 2019 Oct 10 : 134(15)1227-1237 PMCID:PMC6788009 - Brown AL, de Smith AJ, Gant VU, Yang W, Scheurer ME, Walsh KM, Chernus JM, Kallsen Hansen Morimoto L, Kang AY, Smirnov I, J, Laverdi\u00e8re C, Sinnett D, Taub Hunger SP, Pui CH, Loh ML, Zwick ME, Metayer C, Ma X, Mueller BA, Sherman SL, Wiemels JL, Relling MV, Yang JJ, Lupo PJ, Rabin KRInherited genetic susceptibility to acute lymphoblastic leukemia in Down syndrome. 31350265 Blood, 2019 Oct 10 : 134(15)1227-1237 PMCID:PMC6788009 - Carroll AJ, Shago M, Mikhail FM, BA, Gastier-Foster J, Stonerock E, Ell D, Kahwash S, Devidas M, Harvey RC, Chen IL, Willman A report from the Children's Oncology Group. 31425927 Cancer genetics, 2019 Hashmi SK, Punia JN, Marcogliese DH, Ringrose J, azacitidine monotherapy and precursor B-lymphoblast population in juvenile myelomonocytic leukemia. 31250550 Pediatric blood & cancer, 2019 Oct. : 66(10)e27905 PMCID:PMC7328527 - Carroll AJ, Shago M, Mikhail FM, BA, Gastier-Foster J, Stonerock E, Ell D, Kahwash S, Devidas M, Harvey RC, Chen IL, Willman A report from the Children's Oncology Group. 31425927 Cancer 2019 Devidas SP, ALPlasma asparaginase activity and asparagine depletion in acute lymphoblastic treated with pegaspargase on Children's Oncology Group 30626253 ND, Nickl CK, Kang H, Brown R, Ness SA, Loh ML, Mullighan CG, Winter SS, Hunger SP, Cannon JL, Matlawska-Wasowska KEpigenetic of SOCS5 potentiates of T-cell acute lymphoblastic leukemia. 30974024 Cancer science, 2019 June : 110(6)1931-1946 PMCID:PMC6549933 - Robinson KM, Yang W, Karol SE, Kornegay N, Jay D, Cheng C, Choi JK, Campana D, Pui CH, Wood B, Borowitz MJ, Gastier-Foster J, EC, Winick Carroll ML, Raetz EA, Hunger SP, Devidas M, Mardis ER, Fulton RS, Relling MV, Jeha SNo evidence that G6PD deficiency affects the efficacy or safety of daunorubicin in acute lymphoblastic leukemia induction therapy. 30848065 Pediatric blood & cancer, 2019 June : PMCID:PMC6518412 - Diaz-Flores E, Comeaux EQ, Kim Beckman K, Davis KL, Wu K, Akutagawa J, Bridges O, Marino R, Wohlfeil M, Braun BS, Mullighan CG, Loh MLBcl-2 Is a Therapeutic Target for Hypodiploid B-Lineage Acute Lymphoblastic Leukemia. 30862722 Cancer research, 2019 79(9)2339-2351 PMCID:PMC6497548 - Burke MJ, Salzer WL, Devidas M, Rabin KR, Zweidler-McKay PA, Borowitz MJ, Raetz ML, Hunger SPReplacing cyclophosphamide/cytarabine/mercaptopurine with cyclophosphamide/etoposide during consolidation/delayed intensification does not improve outcome for pediatric B-cell acute lymphoblastic leukemia: a report from the COG. 30545921 2019 May : 104(5)986-992 PMCID:PMC6518909 - Bhojwani D, Sposto R, Shah NN, Rodriguez Yuan C, Stetler-Stevenson M, O'Brien MM, McNeer Quereshi A, Cabannes A, Schlegel P, Rossig K, Alexander S, Bourquin JP, M, Raetz EA, Loh ML, Rheingold pediatric patients with relapsed/refractory acute lymphoblastic 30842605 Leukemia, 2019 April : 33(4)1061-1062 PMCID:PMC7608412 - Iacobucci I, Wen J, Meggendorfer M, Choi JK, Shi L, Pounds SB, Li Y, Payne-Turner D, Tomizawa D, Kiyokawa N, Valentine M, Valentine F, Enemark EJ, Kham X, Zhou X, Sioson E, Rusch M, Ries RE, Stieglitz E, Hunger SP, Wei AH, To LB, Lewis ID, D'Andrea RJ, Kile BT, Brown AL, Scott HS, Hahn CN, Marlton P, Pei D, Cheng C, Loh Meshinchi S, Haferlach T, targeting of acute erythroleukemia. 30926971 Nature genetics, 2019 April : 51(4)694-704 PMCID:PMC6828160 - Bhojwani D, Sposto R, Shah NN, Rodriguez Yuan C, Stetler-Stevenson M, O'Brien MM, McNeer Quereshi A, Cabannes A, Schlegel P, Rossig K, Alexander S, Bourquin JP, Zwaan M, Raetz EA, Loh ML, Rheingold SRInotuzumab in pediatric patients with relapsed/refractory acute lymphoblastic leukemia. 30267011 Leukemia, 2019 April : 33(4)884-892 - G, F, L, Lintermans B, Vandamme N, Lammens T, Van Roy N, Van Nieuwerburgh F, Deforce D, Schwab C, Raimondi S, Dalla Pozza L, Carroll AJ 3rd, De Moerloose Benoit Goossens S, Berx G, Harrison H, Sutton R, Asnafi V, Meijerink J, Mullighan C, Loh M, Van Vlierberghe PGenetic characterization and therapeutic targeting of MYC-rearranged T cell acute lymphoblastic leukaemia. 29938777 British journal PMCID:PMC7081658 - McNeer JL, Winick NJ, Schultz Hunger SP, Carroll WL, Loh ML, Raetz EAHematopoietic Stem-Cell Transplantation Does Not Improve the Poor Outcome of Children With Hypodiploid Acute Lymphoblastic Leukemia: A Report From Children's Oncology Group. 30742559 Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2019 Apr 1 : 37(10)780-789 PMCID:PMC6440386 - Kong G, You X, Wen Z, Chang YI, Qian S, Ranheim EA, Letson C, Zhang X, Zhou Y, Liu Y, Rajagopalan A, Zhang J, Stieglitz E, Loh M, Hofmann I, Yang D, Zhong X, Padron E, Zhou L, Pear WS, Zhang JDownregulating 2019 Ferrando AAPhf6 Loss Enhances HSC Self-Renewal Driving Tumor Initiation and Leukemia Stem Cell Activity in T-ALL. 30567843 Cancer discovery, 2019 March : 9(3)436-451 PMCID:PMC6425751 - Wu X, Xu G, Li X, Xu W, Li Q, Liu W, Kirby KA, Loh ML, Li J, Sarafianos SG, Qu CKSmall Molecule Inhibitor that Tyrosine Phosphatase SHP2. 30457860 medicinal chemistry, 2019 Feb 14 : 62(3)1125-1137 PMCID:PMC6467801 - Qian M, Xu H, Perez-Andreu V, Roberts KG, Zhang H, Yang W, Zhang S, Zhao X, Smith C, Devidas M, Gastier-Foster JM, Raetz E, Larsen E, Burchard EG, Winick N, Bowman WP, Martin PL, Borowitz M, Wood B, Antillon-Klussmann F, Pui CH, Mullighan CG, Evans WE, Hunger SP, Relling MV, Loh ML, Yang JJNovel susceptibility variants at the ERG locus for childhood acute lymphoblastic leukemia in Hispanics. 30510082 Blood, 2019 Feb 14 : 133(7)724-729 PMCID:PMC6376278 - Gu Z, Churchman ML, Roberts KG, Moore I, Zhou X, Nakitandwe J, Hagiwara K, Pelletier S, Gingras S, Berns H, Payne-Turner D, Hill A, Iacobucci I, Shi L, Pounds S, Cheng C, Pei D, Qu C, Newman S, Devidas M, Dai Y, Luger S, Litzow MR, Tallman MS, Racevskis J, Zhang Y, Bhatia R, Kohlschmidt J, Mr\u00f3zek K, Bloomfield CD, Stock W, Kornblau S, Kantarjian HM, Konopleva M, Evans WE, Jeha S, Pui CH, Yang J, Paietta E, Downing JR, Relling MV, Zhang J, Loh ML, Hunger SP, Mullighan CGPAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia. : PMCID:PMC6525306 Pouliot GP, Degar J, Hinze Vo CD, Burns MA, Moreau L, Ganesa C, Roderick J, Peirs S, Menten B, Loh ML, Hunger SP, Silverman LB, Harris MH, Stevenson KE, Weinstock DM, Weng AP, Van Vlierberghe P, D'Andrea AD, Gutierrez AFanconi-BRCA pathway mutations in childhood T-cell acute lymphoblastic leukemia. 31721781 one, JA, Posocco D, Gandre-Babbe S, Gagne AL, Liang G, Loh ML, Weiss MJ, French DL, Chou STMutation-specific signaling profiles and kinase inhibitor sensitivities of juvenile myelomonocytic leukemia revealed by induced pluripotent stem cells. 29884903 Leukemia, 2019 Jan. : 33(1)181-190 PMCID:PMC6286697 Pouliot GP, Degar J, Hinze Vo CD, Burns MA, Moreau L, Ganesa C, Roderick J, Peirs S, Menten B, Loh ML, Hunger SP, Silverman LB, Harris MH, Stevenson KE, Weinstock DM, Weng AP, Van Vlierberghe P, D'Andrea AD, Gutierrez AFanconi-BRCA pathway mutations in childhood T-cell acute lymphoblastic leukemia. 31721781 one, 2019 : Karim R, Stevenson KE, Neuberg DS, Devidas M, Loh ML, Hunger SP, Teachey DT, Rabin KR, Winter SS, Dunsmore KP, B, AG, Gutierrez APRC2 loss induces chemoresistance by repressing apoptosis in T cell acute lymphoblastic leukemia. 30404791 The Journal of experimental medicine, 2018 Dec 3 : 215(12)3094-3114 PMCID:PMC6279404 - Rau RE, Loh MLUsing genomics to define pediatric blood cancers and inform practice. 30504323 Hematology. American Society of Hematology. Education Program, 2018 Nov 30 : 2018(1)286-300 PMCID:PMC6245969 - Winter SS, Dunsmore KP, Devidas M, Wood NJ, Carroll WL, Hunger SPImproved Survival for Children and Young Adults With T-Lineage Acute Lymphoblastic Leukemia: 30138085 Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2018 Oct 10 : 36(29)2926-2934 PMCID:PMC6366301 - Alexander TB, Gu Z, Iacobucci I, Dickerson K, Choi JK, Xu B, Payne-Turner D, Yoshihara H, Loh ML, Horan J, Buldini B, Basso G, Elitzur S, de Haas V, Zwaan Yeoh A, Reinhardt D, Tomizawa D, Kiyokawa N, T, De Moerloose B, Catchpoole D, Hori H, Moorman A, Moore AS, Hrusak O, Meshinchi S, Orgel E, Devidas M, Borowitz M, Wood B, Heerema NA, MA, Davidsen LC, Gesuwan P, Marra MA, Ma Y, RA, Jones SJM, Valentine M, Janke LJ, Rubnitz JE, Pui CH, Ding L, Liu Y, Zhang J, Nichols KE, Downing JR, Cao X, Shi L, Pounds S, Newman S, Pei D, Guidry Auvil JM, Gerhard DS, Hunger SP, Inaba H, Mullighan CGThe genetic basis and cell of origin of mixed phenotype acute leukaemia. 30209392 Nature, 2018 Oct. : 562(7727)373-379 PMCID:PMC6195459 - Burns MA, Liao ZW, Yamagata N, Pouliot GP, Stevenson KE, Neuberg DS, Thorner AR, Ducar M, Silverman EA, Hunger SP, Loh ML, Winter SS, Dunsmore KP, Wood B, Devidas M, Harris MH, Silverman LB, Sallan SE, Gutierrez AHedgehog pathway mutations drive oncogenic transformation in high-risk T-cell acute lymphoblastic leukemia. 29654263 Leukemia, 2018 Oct. : 32(10)2126-2137 PMCID:PMC6148437 - Place AE, Goldsmith K, Bourquin JP, Loh ML, Gore L, Morgenstern DA, Sanzgiri Y, Hoffman D, Zhou Y, Ross JA, Prine B, Shebley M, McNamee M, Farazi T, M, Lash-Fleming L, Zwaan CM, Vormoor JAccelerating drug development in pediatric cancer: a novel Phase I study design of venetoclax in relapsed/refractory malignancies. 29595064 Future oncology (London, England), 2018 : 14(21)2115-2129 - Roberts KG, Reshmi SC, Harvey RC, Chen IM, Patel K, Stonerock E, Jenkins H, Dai Y, Valentine M, Gu Z, Zhao Y, Zhang J, Payne-Turner D, Devidas M, Heerema Gastier-Foster Hunger Ph-like ALL in NCI standard-risk patients: a report from the Children's Oncology Group. 29997224 Blood, 2018 Aug 23 : 132(8)815-824 PMCID:PMC6107876 - Gagne AL, Maguire JA, Gandre-Babbe S, Chou ST, Tasian SK, Loh ML, Weiss MJ, Gadue P, French DLGeneration of a human Juvenile myelomonocytic leukemia iPSC line, CHOPi001-A, with a mutation in CBL. 30096712 Stem cell research, 2018 Aug. : 31157-160 PMCID:PMC7885123 - Slayton WB, Schultz KR, Kairalla X, L, Siegel MJ, Raetz EA, Winick NJ, Loh ML, Carroll WL, Hunger SPDasatinib Plus Intensive Chemotherapy in Children, Adolescents, and Young Adults With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Results of Children's Oncology Group Trial AALL0622. 29812996 Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2018 Aug 1 : 36(22)2306-2314 PMCID:PMC6067800 - Perez DR, Woods T, Sharma ND, Hermiston ML, Loh ML, Hunger SP, Winter SS, Chigaev A, Edwards B, Sklar LA, Matlawska-Wasowska KHigh-Throughput Flow Repurposing in T-ALL. 29746793 SLAS discovery : advancing life sciences R & D, 2018 Aug. : 23(7)732-741 PMCID:PMC6292518 - Wong JC, Bryant V, Lamprecht T, Ma J, Walsh M, Schwartz J, Del Pilar Alzamora M, Mullighan CG, Loh ML, Ribeiro R, Downing JR, Carroll WL, Davis J, Gold S, Rogers PC, Israels S, Yanofsky R, Shannon K, Klco JMGermline SAMD9 and SAMD9L mutations are associated with extensive genetic evolution and diverse hematologic outcomes. 30046003 JCI insight, 2018 Jul 26 : 3(14) PMCID:PMC6124395 - Place AE, Pikman Y, Stevenson KE, Harris MH, Pauly M, Sulis ML, Hijiya N, Gore L, Cooper TM, Loh ML, Roti G, Neuberg DS, Hunt SK, Orloff-Parry S, Stegmaier K, Sallan SE, Silverman LBPhase I trial of the mTOR inhibitor everolimus in combination with multi-agent chemotherapy in relapsed childhood acute lymphoblastic leukemia. 29603593 Pediatric blood & cancer, 2018 July : 65(7)e27062 - Burke MJ, Devidas M, Maloney K, Angiolillo A, Schore R, Dunsmore K, Larsen E, Mattano LA Jr, Salzer W, Winter SS, Carroll W, Winick NJ, Loh ML, Raetz E, Hunger SP, Bleyer ASevere pegaspargase hypersensitivity reaction rates (grade 3) with intravenous infusion vs. intramuscular injection: analysis of 54,280 doses administered to 16,534 patients on children's oncology group (COG) clinical trials. 29115886 Leukemia & July : 59(7)1624-1633 PMCID:PMC5940583 - Dvorak CC, Satwani P, Stieglitz E, Cairo MS, Dang H, Pei Q, Gao Y, Wall D, Mazor T, Olshen AB, Parker JS, Kahwash S, Hirsch B, Raimondi S, Patel N, Skeens M, Cooper T, Mehta PA, Grupp SA, Loh MLDisease burden and conditioning regimens in ASCT1221, a randomized phase II trial in children with juvenile myelomonocytic leukemia: A Children's Oncology Group study. 29528181 Pediatric blood & cancer, 2018 July : 65(7)e27034 PMCID:PMC5980696 - Gupta S, Devidas M, Loh ML, Raetz EA, Chen S, Wang C, Brown P, Carroll AJ, Heerema NA, Gastier-Foster JM, Dunsmore KP, Larsen EC, Maloney LA SS, Winick NJ, Carroll WL, Hunger SP, Borowitz MJ, Wood BLFlow-cytometric vs. -morphologic assessment of remission in childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group (COG). 29472723 Leukemia, 2018 June : 32(6)1370-1379 PMCID:PMC5992047 - Churchman ML, Qian M, Te Kronnie G, Zhang R, Yang W, Zhang H, Lana T, Tedrick P, Baskin R, Verbist K, Peters JL, Devidas M, Larsen E, Moore IM, Gu Z, Qu C, Yoshihara H, Porter SN, Pruett-Miller SM, Wu G, Raetz E, Martin PL, Bowman WP, Winick N, Mardis E, Fulton R, Stanulla M, Evans WE, Relling MV, Pui CH, Hunger SP, Loh ML, Handgretinger R, Nichols KE, Yang JJ, Mullighan CGGermline Genetic IKZF1 Variation and Predisposition to Childhood Acute Lymphoblastic Leukemia. 29681510 Cancer cell, 2018 May 14 : 33(5)937-948.e8 PMCID:PMC5953820 - Barredo JC, Hastings C, Lu X, Devidas M, Chen Y, Armstrong D, Winick N, Wood BL, Yanofsky R, Loh M, testicular relapse of B-cell acute treated chemotherapy and response-based testicular radiation: A Children's Oncology Group study. 29286562 Pediatric blood & cancer, 2018 May : 65(5)e26928 PMCID:PMC6136835 - Wood B, Wu D, Crossley B, Dai Y, Williamson D, Gawad C, Borowitz MJ, Devidas M, Maloney KW, Larsen E, Winick N, Raetz E, Carroll WL, Hunger SP, Loh ML, Robins H, Kirsch IMeasurable residual disease detection by high-throughput sequencing improves risk stratification for pediatric B-ALL. 29284596 PMCID:PMC5865233 - Salzer WL, Burke MJ, Devidas M, Chen S, Gore L, Larsen EC, Borowitz M, Wood B, Heerema NA, Carroll AJ, Hilden JM, ML, Raetz EA, NJ, Carroll SPToxicity associated with intensive postinduction therapy incorporating clofarabine in the very high-risk stratum of patients with newly diagnosed high-risk B-lymphoblastic leukemia: A report from the Children's Oncology Group study AALL1131. 29266189 Cancer, 2018 Mar 15 : 124(6)1150-1159 PMCID:PMC5839964 - Tran TH, Harris MH, Nguyen Stevenson KE, Stonerock E, Asselin BL, Athale impact of kinase-activating fusions and IKZF1 deletions in pediatric high-risk B-lineage acute lymphoblastic leukemia. 29507076 Blood advances, 2018 Mar 13 : 2(5)529-533 PMCID:PMC5851421 - Rau RE, Dreyer Z, Choi MR, with acute lymphoblastic leukemia/lymphoblastic from the Children's Oncology Group. 29090524 Pediatric blood & cancer, 2018 March : 65(3) PMCID:PMC5839116 - Bride KL, Vincent TL, Im SY, Aplenc R, Barrett DM, Carroll WL, Carson R, Dai Y, Devidas M, Dunsmore KP, Fuller T, Glisovic-Aplenc T, Horton TM, Hunger SP, Loh ML, Maude SL, Raetz EA, Winter SS, Grupp SA, Hermiston in T-cell acute 29305553 Blood, 2018 Mar 1 : 131(9)995-999 PMCID:PMC5833263 - Qian M, Cao X, Devidas M, Yang W, Cheng C, Dai Y, Carroll A, Heerema NA, Zhang H, Moriyama T, Gastier-Foster JM, Xu H, Raetz E, Larsen E, Winick N, Bowman WP, Martin PL, Mardis ER, Fulton R, Zambetti G, Borowitz M, Wood B, Nichols KE, Carroll WL, Pui CH, Mullighan CG, Evans WE, Hunger SP, Relling MV, Loh ML, Yang JJTP53 Germline Variations Influence the Predisposition and Prognosis of B-Cell Acute Lymphoblastic Leukemia in Children. 29300620 Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2018 Feb 20 : 36(6)591-599 PMCID:PMC5815403 - Zheng DJ, Lu X, M, Winick NJ, Raetz WL, Sung L, Hunger SP, Angiolillo AL, Kadan-Lottick NSLongitudinal analysis of quality-of-life outcomes in children during treatment for acute lymphoblastic leukemia: A report from the Children's Oncology Group AALL0932 trial. 29112230 Cancer, 2018 M, Koh Nature, 2018 H, Sharma ND, JF, Loh MLGenome-wide DNA methylation is predictive of outcome in juvenile myelomonocytic leukemia. 29259179 Nature communications, 2017 Dec 19 : KK, Kairalla JA, Devidas M, S, Carroll WL, Larsen E, Raetz EA, Loh ML, Yang W, Noll RB, NReply to I.J. Cohen. 29045162 Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2017 Dec 10 : 35(35)3989-3991 - Rau RE, Carroll NA, Arland L, Carroll WL, Winick NJ, Raetz EA, Loh ML, Yang W, Relling MV, Dai Y, Devidas M, Hunger SPKlinefelter syndrome and 47,XYY syndrome in children with B cell acute lymphoblastic leukaemia. 27434379 British journal of haematology, 2017 Dec. Tasian SPPhiladelphia chromosome-like leukemia. Blood, 2017 Nov 9 130(19)2064-2072 PMCID:PMC5680607 - Tran TH, Shah AT, Loh MLPrecision Medicine in Pediatric Oncology: Translating Genomic Discoveries into Optimized Therapies. 28600472 Clinical cancer research : an official journal of the American Association for Cancer Research, 2017 Sep 15 : 23(18)5329-5338 - Roberts KG, Yang YL, Payne-Turner D, Lin W, Files JK, Dickerson K, Gu Z, Taunton J, Janke LJ, Chen T, Loh ML, Hunger SP, Mullighan CGOncogenic role and therapeutic targeting of ABL-class and JAK-STAT activating kinase alterations in Ph-like ALL. 29296813 Blood advances, 2017 Sep 12 : 1(20)1657-1671 PMCID:PMC5728345 - Hardy KK, Embry L, Kairalla JA, Helian S, Devidas M, Armstrong D, Hunger S, Carroll WL, Larsen E, Raetz EA, Loh ML, Yang W, Relling MV, Noll RB, Winick NNeurocognitive Functioning of Children Treated for High-Risk B-Acute Lymphoblastic Leukemia Randomly Assigned to Different Methotrexate and Corticosteroid Treatment Strategies: A Report From the Children's Oncology Group. 28671857 Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2017 Aug 10 : 35(23)2700-2707 PMCID:PMC5549456 - Liu Y, Easton J, Shao Y, Maciaszek J, Wang Z, Wilkinson MR, McCastlain K, Edmonson M, Pounds SB, Shi L, Zhou X, Ma X, Sioson E, Li Y, Rusch M, Gupta P, Pei D, Cheng C, Smith MA, Auvil JG, Gerhard DS, Relling MV, Winick NJ, Carroll AJ, Heerema NA, Raetz CL, KP, Winter SS, Wood BL, Sorrentino BP, Downing JR, Loh ML, Hunger SP, Zhang J, Mullighan CGThe genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia. 28671688 Nature genetics, 2017 Aug. : 49(8)1211-1218 PMCID:PMC5535770 - Winick N, Devidas M, Chen S, Maloney K, Larsen E, Mattano L, Borowitz MJ, Carroll A, Gastier-Foster JM, Heerema NA, Willman C, Wood B, Loh ML, Raetz E, Hunger SP, Carroll WLImpact of Initial CSF Findings on Outcome Among Patients With National Cancer Institute Standard- and High-Risk B-Cell Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group. 28535084 Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2017 Aug 1 : 35(22)2527-2534 PMCID:PMC5536164 - Yoshimi A, Balasis ME, Vedder A, Feldman K, Ma Y, Zhang H, Lee SC, Letson C, Niyongere S, Lu SX, Ball M, Taylor J, Zhang Q, Zhao Y, Youssef S, Chung YR, Zhang XJ, Durham BH, Yang W, List AF, Loh ML, Klimek MF, Stieglitz E, Abdel-Wahab ORobust patient-derived xenografts of MDS/MPN of CMML and JMML. 28576879 2017 SC, Harvey RC, Roberts KG, Stonerock E, Smith A, Jenkins H, Chen IM, Valentine M, Liu Y, Li Y, Shao Y, Easton J, Payne-Turner D, Gu Z, Tran TH, Nguyen JV, Devidas M, Dai Y, Heerema from the Children's Oncology Group. 28408464 Blood, 2017 Jun 22 : Kruth KA, Fang M, Shelton DN, Abu-Halawa Mahling R, Yang H, B-cell development genes is key to glucocorticoid efficacy in treatment of acute lymphoblastic leukemia. 28424165 Blood, 2017 Jun 1 : 129(22)3000-3008 PMCID:PMC5454339 - Sherborne AL, Lavergne V, Yu K, Lee L, Davidson PR, Mazor T, Smirnoff IV, Horvai AE, Loh M, DuBois SG, Goldsby RE, Neglia JP, Hammond S, Robison LL, Wustrack R, Costello JF, Nakamura AO, Shannon KM, Bhatia S, Nakamura JLSomatic and Germline TP53 Alterations in Second Malignant Neoplasms from Pediatric Cancer Survivors. 27683180 Clinical cancer research : an official journal of the American Association for Cancer Research, 2017 Apr 1 : 23(7)1852-1861 PMCID:PMC5570538 - Frismantas V, Dobay Rinaldi Dunn SH, Kunz J, Richter-Pechanska P, Marovca B, Pail O, Jenni S, Diaz-Flores E, Chang BH, Brown TJ, Collins MU, JA, R, T, Von Stackelberg A, Eckert Horvath P, Bornhauser BC, Bourquin JPEx vivo drug response profiling detects recurrent sensitivity patterns in drug-resistant acute lymphoblastic leukemia. 28122742 Blood, 2017 Mar 16 : 129(11)e26-e37 PMCID:PMC5356455 - Tasian SK, Teachey DT, Li Y, Shen F, Harvey RC, Chen IM, Ryan T, Vincent TL, Willman CL, Perl AE, Hunger SP, Loh ML, Carroll M, Grupp SAPotent efficacy of combined PI3K/mTOR and JAK or murine Ph-like 12 Loh acute lymphoblastic leukemia. 27913529 Hematology. American Society of Hematology. Education Program, 2016 Dec 2 : 2016(1)561-566 PMCID:PMC6142516 - Zhang J, McCastlain K, Yoshihara H, Xu B, Chang Y, Churchman ML, Wu G, Li Y, Wei L, Iacobucci I, Liu Y, Qu C, Wen J, Edmonson M, Payne-Turner D, Kaufmann KB, Takayanagi SI, Wienholds E, Ntziachristos P, Bakogianni S, Wang J, Aifantis I, Roberts KG, Ma J, Song G, Easton J, Mulder HL, Chen X, Newman S, Ma X, Rusch M, Gupta P, Boggs K, Vadodaria B, Dalton J, Liu Y, Valentine ML, Ding L, Lu C, Fulton RS, Fulton L, Tabib Y, Ochoa K, Devidas M, Pei D, Cheng C, Yang J, Evans WE, Relling MV, Pui CH, Jeha S, Harvey RC, Chen IL, Willman CL, Marcucci Bloomfield CD, Kohlschmidt J, Mr\u00f3zek K, Paietta E, Tallman MS, Stock Wilson RK, JE, Hunger SP, Loh ML, Downing JR, Mullighan CG, St. Jude Children's Research Hospital-Washington University Pediatric Cancer Genome ProjectDeregulation of DUX4 and ERG in acute lymphoblastic leukemia. 27776115 Nature genetics, 2016 Dec. : 48(12)1481-1489 PMCID:PMC5144107 - Dong L, Yu WM, Zheng H, Loh ML, Bunting ST, Pauly M, Huang G, Zhou M, Broxmeyer HE, Scadden DT, Qu CKLeukaemogenic effects of Ptpn11 activating mutations in the stem cell microenvironment. 27783593 Nature, 2016 Nov 10 : 539(7628)304-308 PMCID:PMC5317374 - Gu Z, Churchman M, Roberts K, Li Y, Liu Y, Harvey RC, McCastlain K, Reshmi SC, Payne-Turner D, Iacobucci I, Shao Chen IM, Valentine M, Pei D, Mungall KL, Mungall AJ, Ma Y, Moore R, Marra M, Stonerock E, Gastier-Foster JM, Devidas M, Dai Y, Wood B, Borowitz M, Larsen EE, Maloney K, Mattano LA Jr, Angiolillo Salzer WL, Burke Spinelli O, Radich JP, Minden MD, Moorman AV, Patel B, Fielding AK, Rowe JM, Luger SM, Bhatia R, Aldoss I, Forman SJ, Kohlschmidt Mr\u00f3zek K, Marcucci G, Bloomfield CD, Stock W, Kornblau S, Kantarjian HM, Konopleva M, Paietta E, Willman CL, Loh ML, Hunger SP, Mullighan CGGenomic identify recurrent MEF2D fusions in acute lymphoblastic 27824051 Nature communications, 2016 Nov 8 : 713331 PMCID:PMC5105166 - Ceremsak JJ, Yu A, Esquivel E, Lissewski C, Zenker M, Loh ML, Stieglitz EGermline RRAS2 mutations are not associated with Noonan syndrome. 27055474 Journal of medical genetics, 2016 Nov. : 53(11)728 - Oshima K, Khiabanian H, da Silva-Almeida AC, Tzoneva G, Abate F, Ambesi-Impiombato A, Sanchez-Martin M, Carpenter Z, Penson A, Perez-Garcia A, Eckert C, Nicolas C, Balbin M, Sulis ML, Kato M, Koh K, Paganin R, Ferrando AAMutational landscape, clonal evolution patterns, and role of RAS mutations in relapsed acute lymphoblastic leukemia. 27655895 Proceedings of the National Academy of Sciences of the United States of America, 2016 Oct 4 : 113(40)11306-11311 PMCID:PMC5056035 - Zaliova M, Moorman AV, Cazzaniga G, Stanulla Harvey RC, Roberts KG, Heatley SL, Loh ML, Konopleva M, Chen IM, Zimmermannova O, Schwab C, Smith O, Mozziconacci MJ, Chabannon C, Kim M, Frederik Falkenburg Marshall K, Haas OA, Starkova J, Stuchly J, Hunger SP, White Salzer WL, Hunger SP, Dreyer ZEA Pilot Study of Intensified PEG-Asparaginase in High-risk Acute Lymphoblastic Leukemia: Children's Oncology Group Study 2016 Aug. : 38(6)409-17 PMCID:PMC4955695 - Larsen EC, Devidas Chen S, Salzer WL, Raetz EA, Loh ML, LA Eicher A, Haugan M, Carroll WLDexamethasone and High-Dose Methotrexate Improve Outcome for Children and Young Adults With High-Risk B-Acute Lymphoblastic Leukemia: A Report From Children's Oncology Group Study AALL0232. 27114587 Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2016 Jul 10 : 34(20)2380-8 PMCID:PMC4981974 - Liu C, Yang W, Devidas M, Cheng C, Pei D, Smith C, Carroll WL, Raetz EA, Bowman WP, Larsen EC, Maloney KW, Martin PL, Mattano LA Jr, Winick NJ, Mardis ER, Fulton RS, Bhojwani D, Howard SC, Jeha S, Pui CH, Hunger SP, Evans WE, Loh ML, Relling MVClinical and Genetic Risk Factors for Acute Pancreatitis in Patients With Acute Lymphoblastic Leukemia. 27114598 Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2016 Jun 20 : 34(18)2133-40 PMCID:PMC4962704 - Chen Z, Shojaee S, Buchner M, Geng H, Lee JW, Klemm L, Titz B, Graeber TG, Park E, Tan A, Paietta E, Hunger SP, Willman CL, Melnick A, Loh ML, Jung JU, Coligan JE, Bolland S, Mak TW, Limnander A, Jumaa H, Reth M, Weiss A, Lowell CA, M\u00fcschen MCorrigendum: Signalling thresholds and negative B-cell selection in acute lymphoblastic leukaemia. 26958840 Nature, 2016 Jun 2 : 534(7605)138 - E, Loh MLPediatric MDS: GATA screen the germline. 26989184 - Hungate Vora SR, Gamazon ER, Moriyama T, Best T, Hulur I, Lee Y, Evans TJ, Ellinghaus E, Stanulla M, Rudant J, Orsi L, Clavel J, Milne E, Scott RJ, Pui CH, Cox NJ, Loh ML, Yang JJ, Skol AD, Onel KA variant at 9p21.3 Feb 12 : 710635 PMCID:PMC4754340 - Iacobucci I, Li Y, Roberts KG, Dobson SM, Kim JC, Payne-Turner D, Harvey RC, Valentine M, McCastlain K, Easton J, Yergeau D, Janke Gastier-Foster J, Gu Z, Reshmi S, Loh ML, Racevskis MS, Wiernik PH, Litzow MR, Willman CL, McPherson JD, Downing JR, Zhang J, Dick JE, Hunger SP, Mullighan CGTruncating Erythropoietin Receptor Rearrangements in Acute Lymphoblastic Leukemia. 26859458 Cancer cell, 2016 Feb 8 : 29(2)186-200 PMCID:PMC4750652 - White Y, Bagchi A, Van Ziffle J, Inguva A, Bollag G, Zhang C, Carias H, Dickens D, Loh M, Shannon K, Firestone AJKRAS insertion mutations are oncogenic and exhibit distinct functional properties. 26854029 Nature communications, 2016 Feb 8 : 710647 PMCID:PMC4748120 - Karol SE, Mattano LA Jr, Yang W, Maloney KW, Smith C, Liu C, Ramsey LB, Fernandez CA, Chang TY, Neale G, Cheng C, Mardis E, Fulton R, Scheet P, San Lucas FA, Larsen EC, Loh ML, Raetz EA, Hunger SP, Devidas M, Relling MVGenetic risk factors for the development of osteonecrosis in children under age 10 treated for acute lymphoblastic leukemia. 26590194 Blood, 2016 Feb 4 : 127(5)558-64 PMCID:PMC4742546 - Mitchell HR, Lu X, Myers RM, Sung L, Balsamo LM, Carroll WL, Raetz E, Loh ML, Mattano LA Jr, Winick NJ, Devidas M, Hunger SP, Maloney K, Kadan-Lottick NSProspective, longitudinal assessment of quality of life in children from diagnosis to 3 months off treatment for standard risk acute lymphoblastic leukemia: Results of Children's Oncology Group study AALL0331. 26235006 International journal of cancer, 2016 Jan 15 : 138(2)332-9 PMCID:PMC5138856 - Stieglitz E, Taylor-Weiner AN, Chang TY, Gelston Wang YD, Mazor T, Esquivel E, Yu A, Seepo S, Olsen SR, Rosenberg M, Archambeault SL, Abusin G, Beckman K, Brown PA, Briones M, Carcamo B, JA, Costello JF, Olshen AB, Stewart C, Li Y, Ma J, Gerbing RB, Alonzo TA, Getz G, Gruber TA, Golub TR, Stegmaier K, Loh MLCorrigendum: The genomic landscape of juvenile myelomonocytic leukemia. 26711114 Nature genetics, 2016 Jan. : 48(1)101 - Moriyama T, Metzger ML, Wu G, Nishii R, Qian M, Devidas M, Yang W, Cheng C, Cao X, Quinn E, Raimondi S, Gastier-Foster JM, Raetz E, Larsen E, Martin PL, Bowman WP, Winick N, Komada Y, Wang S, Edmonson M, Xu H, Mardis E, Fulton R, Pui CH, Mullighan C, Evans WE, Zhang J, Hunger SP, Relling MV, Nichols KE, Loh ML, Yang JJGermline genetic variation in ETV6 and risk of childhood acute lymphoblastic leukaemia: a systematic genetic study. 26522332 The Lancet. Oncology, 2015 Dec. : 16(16)1659-66 PMCID:PMC4684709 CL, Gearheart Fosmire Evensen NA, Bride Waanders AJ, Pais F, Wang J, Bhatla T, Bitterman DS, de Rijk SR, Bourgeois W, Dandekar EA, Hermiston SP, Zhang J, Garabedian MJ, Porter CC, Carroll WLMAPK signaling cascades mediate distinct glucocorticoid resistance mechanisms in pediatric leukemia. 26324703 Blood, 2015 Nov 5 : 126(19)2202-12 PMCID:PMC4635116 - Stieglitz E, Taylor-Weiner AN, Chang TY, Gelston Wang YD, Mazor T, Esquivel E, Yu A, Seepo S, Olsen S, Rosenberg M, Archambeault SL, Abusin G, Beckman K, Brown PA, Briones M, Carcamo B, JA, Costello JF, Olshen AB, Stewart C, Li Y, Ma J, Gerbing RB, Alonzo TA, Getz G, Gruber T, Golub T, Stegmaier K, Loh MLThe genomic landscape of juvenile myelomonocytic leukemia. 26457647 Nature genetics, 2015 Nov. : 47(11)1326-1333 PMCID:PMC4626387 - Tasian SK, Loh ML, Hunger SPChildhood acute lymphoblastic leukemia: Integrating genomics into therapy. 26194091 Cancer, 2015 Oct 15 : 121(20)3577-90 PMCID:PMC4592406 - Karol SE, Yang W, Van Driest SL, Chang TY, Kaste S, Bowton E, Basford M, Bastarache L, Roden DM, Denny JC, Larsen E, Winick N, Carroll WL, Cheng C, Pei D, Fernandez CA, Liu C, Smith C, Loh ML, Raetz EA, Hunger SP, Scheet P, Jeha S, Pui LA Jr, Relling MVGenetics glucocorticoid-associated osteonecrosis in children with acute lymphoblastic leukemia. 26265699 Blood, 2015 Oct 8 : 126(15)1770-6 PMCID:PMC4600016 - Loh ML, Tasian SK, Rabin KR, Brown P, Magoon D, Reid JM, Chen X, Ahern CH, Weigel BJ, Blaney SMA phase 1 dosing study of ruxolitinib in children with relapsed or refractory solid tumors, leukemias, or myeloproliferative neoplasms: A Children's Oncology Group phase 1 consortium study (ADVL1011). 25976292 Pediatric blood & cancer, 2015 Oct. : 62(10)1717-24 PMCID:PMC4546537 - Borowitz Y, Winick NJ, Hunger SP, Carroll WL, Larsen EPrognostic significance of minimal residual disease in high risk B-ALL: a report from Children's Oncology Group study AALL0232. 26124497 Blood, 2015 Aug 20 : 126(8)964-71 PMCID:PMC4543229 - Fernandez CA, Smith C, Yang W, Mullighan CG, Qu C, Larsen E, Bowman WP, Liu C, Ramsey LB, Chang T, Karol SE, Loh ML, Raetz EA, Winick NJ, Hunger SP, Carroll WL, Evans WE, links NFATC2 Blood, PMCID:PMC4492197 SS, Dunsmore KP, MS, Murphy J, AJ, NA, ML, Raetz NJ, Carroll WL, Hunger SPSafe integration of nelarabine into intensive chemotherapy in newly diagnosed acute lymphoblastic leukemia: Children's Oncology Group Study AALL0434. blood & cancer, 2015 July : 62(7)1176-83 PMCID:PMC4433576 - Xu H, Zhang H, Yang W, Yadav R, Morrison AC, Qian M, Devidas M, Liu Y, Perez-Andreu V, Zhao X, Gastier-Foster JM, Lupo PJ, Neale G, Raetz E, Larsen E, Bowman WP, Carroll WL, Winick N, Williams R, Hansen T, Holm JC, Mardis E, Fulton R, Pui CH, Zhang J, Mullighan CG, Evans WE, Hunger SP, Gupta R, Schmiegelow K, Loh ML, Relling MV, Yang JJInherited coding variants at the CDKN2A locus influence susceptibility to acute lymphoblastic leukaemia in children. 26104880 Nature communications, 2015 Jun 24 : 67553 PMCID:PMC4544058 - Chen Z, Shojaee S, Buchner M, Geng H, Lee JW, Klemm L, Titz B, Graeber TG, Park E, Tan A, Paietta E, Hunger SP, Willman CL, Melnick A, Loh ML, Jung JU, Coligan JE, Bolland S, Mak TW, Limnander A, Jumaa H, Reth M, Weiss A, Lowell CA, M\u00fcschen MSignalling and negative B-cell selection in acute 25799995 Nature, 2015 May 21 : 521(7552)357-61 PMCID:PMC4441554 E, Ward AF, N, Balis Castleberry RP, Bunin NJ, Loh farnesyl transferase the Children's Oncology Group. 25704135 Pediatric blood & cancer, 2015 April : 62(4)629-36 PMCID:PMC4339233 - Ma X, Edmonson M, Yergeau D, Muzny DM, Hampton OA, Rusch M, Song G, Easton J, Harvey RC, Wheeler DA, Ma J, Doddapaneni H, Vadodaria B, Wu G, Nagahawatte P, Carroll WL, Chen IM, Gastier-Foster JM, Relling MV, Smith MA, Devidas M, Guidry Auvil JM, Downing JR, Loh ML, Willman CL, Gerhard DS, Mullighan CG, Hunger SP, Zhang JRise and fall of subclones diagnosis to relapse in pediatric B-acute lymphoblastic leukaemia. 25790293 Nature communications, 2015 Mar 19 : 66604 PMCID:PMC4377644 - Maude SL, Dolai S, Delgado-Martin C, Vincent T, Robbins A, Selvanathan A, Ryan T, Hall J, Wood AC, Tasian SK, Hunger SP, Loh ML, Mullighan CG, Wood BL, ML, T-cell precursor (ETP) acute lymphoblastic leukemia. 25645356 Blood, 2015 Mar 12 : 125(11)1759-67 PMCID:PMC4357583 - Geng H, Hurtz C, Lenz KB, Chen Z, Baumjohann D, Thompson S, Goloviznina NA, Chen WY, Huan J, LaTocha D, Ballabio E, Xiao G, Lee JW, Deucher A, Qi Z, Park E, Huang C, Nahar R, Kweon SM, Shojaee S, JW, Loh ML, Roeder RG, JA, TA, MSelf-enforcing feedback activation between BCL6 and pre-B cell receptor signaling defines a distinct subtype of acute lymphoblastic leukemia. 25759025 Cancer cell, 2015 Mar : 27(3)409-25 PMCID:PMC4618684 - Salzer WL, Jones TL, Devidas M, Dreyer ZE, Gore L, Winick NJ, Sung L, Raetz E, Loh ML, Wang CY, De Lorenzo P, Valsecchi MG, Pieters R, Carroll WL, Hunger SP, Hilden JM, Brown PDecreased induction morbidity and mortality following modification to induction therapy in infants with acute lymphoblastic leukemia enrolled on AALL0631: a report from the Children's Oncology Group. 25407157 Pediatric blood & cancer, 2015 March : 62(3)414-8 PMCID:PMC4480675 - Diouf B, Crews KR, Lew G, Pei D, Cheng C, Bao J, Zheng JJ, Yang W, Fan Y, Wheeler HE, Wing C, Delaney SM, Komatsu M, Paugh SW, McCorkle JR, Lu X, Winick NJ, Carroll WL, Loh ML, Hunger SP, Devidas M, Pui CH, Dolan ME, Relling MV, Evans WEAssociation of an inherited genetic variant with vincristine-related peripheral neuropathy in children with acute lymphoblastic leukemia. 25710658 JAMA, 2015 Feb 24 : 313(8)815-23 PMCID:PMC4377066 - Suryani S, Bracken LS, Harvey RC, Sia KC, Carol H, Chen IM, Evans K, Dietrich PA, Roberts KG, Kurmasheva RT, Billups CA, Mullighan CG, Willman CL, Loh ML, Hunger SP, Houghton PJ, Smith MA, Lock RBEvaluation of the in vitro and in vivo efficacy of the JAK inhibitor AZD1480 against JAK-mutated acute lymphoblastic leukemia. 25504635 2015 Feb. : 14(2)364-74 PMCID:PMC4326541 - Perez-Andreu V, Roberts KG, Xu H, Smith C, Zhang H, Yang W, Harvey RC, Payne-Turner D, Devidas M, Cheng IM, Wang Y, Pui CH, Jeha S, Relling MV, Evans WE, Gerhard DS, Loh ML, Willman CL, Hunger SP, Mullighan CG, Yang JJA genome-wide association study of susceptibility to acute lymphoblastic leukemia in adolescents and young adults. 25468567 Blood, 2015 Jan 22 : 125(4)680-6 PMCID:PMC4304112 - Stieglitz E, Troup CB, Gelston LC, Haliburton J, Chow ED, Yu KB, Akutagawa J, Taylor-Weiner AN, Liu YL, Wang YD, Beckman K, Emanuel PD, Braun BS, Abate A, Gerbing RB, Alonzo TA, Loh MLSubclonal mutations in SETBP1 confer a poor prognosis in juvenile myelomonocytic leukemia. 25395418 Blood, 2015 Jan 15 : 125(3)516-24 PMCID:PMC4296011 Baughn LB, Biegel JA, South ST, S, Carroll AJ, Heerema NA, Rabin KR, Zweidler-McKay PA, Loh M, Hirsch BIntegration of cytogenomic data for furthering the characterization of pediatric acute lymphoblastic leukemia: a multi-institution, multi-platform : 208(1-2)1-18 PMCID:PMC5361577 - Niemeyer CM, Loh ML, Cseh A, Cooper Dvorak CC, Chan R, Xicoy B, U, A, Dworzak M, Moerloose Star\u00fd Smith Masetti Catala den Heuvel-Eibrink MM, Flotho C, Yoshimi ACriteria for evaluating response and outcome in clinical trials for children with juvenile myelomonocytic leukemia. 25552679 Haematologica, 2015 Jan. : 100(1)17-22 PMCID:PMC4281308 - Mansour MR, Abraham BJ, Anders L, Berezovskaya A, Gutierrez A, Durbin AD, Etchin J, Lawton L, Sallan SE, Silverman LB, Loh ML, Hunger SP, Sanda T, Young RA, Look ATOncogene regulation. An oncogenic super-enhancer formed through somatic mutation of a noncoding intergenic element. 25394790 Science (New York, N.Y.), 2014 Dec : 346(6215)1373-7 - Angiolillo T, Lane AR, Loh ML, Reaman GH, Adamson PC, Wood B, Wood C, Zheng HW, EA, Winick NJ, calaspargase pegol Escherichia coli L-asparaginase in the treatment of patients with acute lymphoblastic leukemia: results from Children's Oncology Group Study AALL07P4. 25348002 Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2014 Dec 1 : 32(34)3874-82 PMCID:PMC4239306 - Chang TY, Dvorak CC, Loh MLBedside to bench in juvenile myelomonocytic leukemia: insights into leukemogenesis from a rare pediatric leukemia. 25163700 Blood, 2014 Oct 16 : 124(16)2487-97 - Roberts KG, Li Y, Payne-Turner D, Harvey RC, Yang YL, Pei D, McCastlain K, Ding L, Lu C, Song G, Ma J, Becksfort J, Rusch M, Chen SC, Easton J, Cheng J, Boggs K, Santiago-Morales N, Iacobucci I, Fulton RS, Wen J, Valentine M, Cheng C, Paugh SW, Devidas M, Chen IM, Reshmi S, Smith A, Hedlund E, Gupta P, Nagahawatte P, Wu G, Chen X, Yergeau D, Vadodaria B, Mulder H, Winick NJ, Larsen EC, Carroll WL, Heerema NA, Carroll AJ, Grayson G, Tasian SK, Moore AS, Keller F, Frei-Jones M, Whitlock JA, Raetz EA, White DL, Hughes TP, Auvil Smith MA, Marcucci G, Bloomfield Kohlschmidt J, Stock E, Pui CH, WE, Gerhard DS, Gastier-Foster JM, Mardis E, Wilson RK, Loh ML, Downing JR, Hunger SP, Willman CL, Zhang J, Mullighan CGTargetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia. 25207766 The New England journal of medicine, 2014 Sep 11 : 371(11)1005-15 PMCID:PMC4191900 - Wu D, Emerson RO, Sherwood A, Loh ML, Angiolillo A, Howie B, Vogt J, Rieder M, Kirsch I, Carlson C, Williamson D, Wood BL, Robins HDetection of minimal residual disease in B lymphoblastic leukemia by high-throughput sequencing of IGH. 24970842 Clinical cancer research : an official journal of the American Association for Cancer Research, 2014 Sep 1 : 20(17)4540-8 PMCID:PMC5142743 - Chonghaile TN, Roderick JE, Glenfield C, Ryan J, Sallan SE, Silverman LB, Loh ML, Hunger SP, Wood B, DeAngelo DJ, Stone R, Harris M, Gutierrez A, Kelliher MA, Letai AMaturation stage of T-cell acute lymphoblastic leukemia BCL-2 versus BCL-XL dependence and sensitivity to ABT-199. 24994123 Cancer discovery, 2014 Sept. : 4(9)1074-87 PMCID:PMC4154982 - Fernandez CA, Smith C, Yang W, Dat\u00e9 M, Bashford D, Larsen E, Bowman WP, Liu C, Ramsey LB, Chang T, Turner V, Loh ML, Raetz EA, Winick NJ, Hunger SP, Carroll WL, Onengut-Gumuscu WM, Concannon P, Rich SS, Scheet S, Pui CH, Evans WE, Devidas M, Relling MVHLA-DRB1*07:01 is associated with a higher risk of asparaginase allergies. 24970932 Blood, 2014 Aug 21 : 124(8)1266-76 PMCID:PMC4141516 - Flex E, Jaiswal Paolacci Stellacci E, Cecchetti S, Ferese R, Bottero L, Castro S, Fenneteau O, Brethon B, Sanchez M, Roberts AE, Yntema HG, Der I, Cianci P, Bondeson ML, Cristina Digilio M, Zampino G, Kerr B, Aoki Y, Loh ML, Palleschi A, Di Schiavi E, Car\u00e8 A, Selicorni A, underlie a phenotype within the RASopathy spectrum and contribute to leukaemogenesis. 24705357 Human molecular genetics, 2014 Aug 15 : 23(16)4315-27 PMCID:PMC4103678 - Goodwin CB, Li XJ, Mali RS, Chan G, Kang M, Liu Z, Vanhaesebroeck B, Neel BG, Loh ML, in a JMML. 24553178 Blood, 2014 May 1 : 123(18)2838-42 PMCID:PMC4007610 - Stieglitz E, Liu YL, Emanuel PD, Castleberry RP, Cooper TM, Shannon KM, Loh MLMutations in GATA2 are rare in juvenile myelomonocytic leukemia. 24578498 Blood, 2014 Feb 27 : 123(9)1426-7 PMCID:PMC3938154 - Kang G, Bi W, Zhao Y, Zhang JF, Yang JJ, Xu H, Loh ML, Hunger SP, Relling MV, Pounds S, Cheng CA new system identification approach to identify genetic variants in sequencing studies for a binary phenotype. 25096228 Human MLJuvenile myelomonocytic current approaches to therapy and hematopoietic cell transplantation. 24734223 Frontiers in pediatrics, 2014 : 225 PMCID:PMC3975112 - Perez-Andreu V, Roberts KG, Harvey RC, Yang W, Cheng C, Pei D, Xu H, Gastier-Foster J, E S, Lim JY, Chen IM, Fan Y, Devidas M, E, Wood B, Yue F, Carroll WL, Larsen E, Bowman WP, Loh ML, Dean M, Bhojwani D, Pui CH, Evans WE, Relling MV, CL, Yang variants are associated acute lymphoblastic leukemia and risk of relapse. 24141364 Nature genetics, 2013 Dec. : 45(12)1494-8 PMCID:PMC4039076 - Liu W, Yu B, Xu G, Xu WR, Loh ML, Tang LD, Qu CKIdentification of SHP2 (PTPN11). 23957426 2013 Sep 26 : 56(18)7212-21 PMCID:PMC4159095 - Heerema NA, Carroll AJ, Devidas Borowitz MJ, Gastier-Foster JM, Larsen Carroll WL, Hunger SP, Raetz EAIntrachromosomal amplification of chromosome 21 is associated with inferior outcomes in children with acute lymphoblastic leukemia treated in contemporary standard-risk children's oncology group studies: a report from the children's oncology group. 23940221 Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013 Sep 20 : 31(27)3397-402 PMCID:PMC3770866 - Yu B, Liu W, Yu WM, Loh ML, Alter S, Guvench O, Mackerell AD Jr, Tang LD, Qu CKTargeting therapeutics, 2013 Schultz RK, Baker KS, Boelens JJ, Bollard Egeler RM, Cowan M, Ladenstein R, Lankester A, Locatelli F, Lawitschka A, Levine VK, Rocha V, Shenoy P, D, Bader P, Grupp SA, Pulsipher MA, Peters CChallenges and opportunities for international cooperative studies in pediatric hematopoeitic cell transplantation: priorities of the Westhafen Intercontinental Group. 23883618 Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2013 Sept. : 19(9)1279-87 PMCID:PMC4198148 - Stieglitz E, Loh MLGenetic predispositions to childhood leukemia. 23926459 Therapeutic advances in hematology, Rodig SJ, Garcia-Manero G, Kantarjian HM, Look ATMYBL2 tumor suppressor gene in myeloid malignancy. 23878725 eLife, 2013 Jul 16 : 2e00825 PMCID:PMC3713455 Gandre-Babbe S, Paluru P, Aribeana C, Chou ST, Bresolin S, Lu L, Sullivan SK, Tasian SK, Weng J, Favre H, Choi JK, French DL, Loh ML, Weiss MJPatient-derived induced pluripotent stem cells recapitulate hematopoietic abnormalities of juvenile myelomonocytic leukemia. 23620576 Blood, 2013 Jun 13 : 121(24)4925-9 PMCID:PMC3682343 - Xu H, Yang W, Perez-Andreu V, Devidas M, Fan Y, Cheng C, Pei D, Scheet P, Burchard EG, Eng C, Huntsman S, M, NJ, Martin Willman CL, WL, Mullighan D, Hunger SP, Pui CH, Evans WE, Relling MV, Loh ML, Yang JJNovel susceptibility variants at 10p12.31-12.2 for childhood acute lymphoblastic leukemia in ethnically diverse populations. 23512250 Journal of the National Cancer Institute, 2013 May 15 : 105(10)733-42 PMCID:PMC3691938 - Bunda S, Kang MW, Sybingco SS, Weng H, DH, that underlies juvenile leukemia. 23400592 Cancer research, 2013 Apr 15 : 73(8)2540-50 - Hartzell C, Ksionda O, Lemmens E, Coakley K, Yang M, Dail M, Harvey RC, Govern C, Bakker J, Lenstra TL, Ammon K, Boeter A, Winter SS, Loh M, Shannon K, Chakraborty AK, Wabl M, Roose JPDysregulated RasGRP1 responds to cytokine receptor input in T cell leukemogenesis. 23532335 Science signaling, 2013 Mar 26 : 6(268)ra21 PMCID:PMC3737252 - Holmfeldt L, Wei L, Diaz-Flores E, Walsh M, Zhang J, Ding L, Payne-Turner D, Churchman M, Andersson A, Chen SC, McCastlain K, Becksfort J, Ma J, Wu G, Patel SN, Heatley SL, Phillips LA, Song G, Easton J, Parker M, Chen X, Rusch M, Boggs K, Vadodaria B, Hedlund E, Drenberg C, Baker S, Pei D, Cheng C, Huether R, Lu C, Fulton RS, Fulton LL, Tabib Y, Dooling DJ, Ochoa K, Minden M, Lewis ID, To LB, Marlton P, Roberts AW, Raca G, Stock ML, Mullighan CGThe genomic landscape of hypodiploid acute lymphoblastic leukemia. 23334668 Nature genetics, 2013 March : 45(3)242-52 PMCID:PMC3919793 - Overview - Board Certification(s) - Pediatric Hematology-Oncology - Medical/Professional School - Columbia University College of Physicians & Surgeons, New York, NY - Residency - Boston Children's Hospital, Boston, MA - Fellowship - Boston Children's Hospital, Boston, MA "}